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Prion proteins are proteins capable of infectious amyloid formation. The conformational 
switch from the soluble form of the protein to the amyloid form is self-perpetuating. The 
N-terminal domains of these proteins are often low complexity regions, rich in glutamine 
amino acid residues and amino acid repeat sequences. Forkhead box G 1 (FoxG 1) belongs 
to the family of HNF-3/ fork head genes, encoding winged-helix transcription factors. 
Expression is restricted to the olfactory neuroepithelium and the telencephalon of the 
developing forebrain, in vertebrate embryos. It has been suggested that FoxG 1 regulates 
the proliferation of progenitor cells and prevents premature differentiation of neurons in a 
dosage dependent manner, leading to the expansion of the cerebral cortex. The N-
terminal domains (NFoxG I domains) of mammalian FoxG I orthologues are low 
complexity regions, rich in histidine, proline and glutamine amino acid residues. As these 
low complexity domains are typical of the N-terminal domains of prion proteins, I have 
tested the hypothesis that the NFoxG 1 domains act as a prion-like switch. 
The N-terminal domains of the human and rat orthologues were fused to a constitutively 
active rat glucocorticoid receptor (GR526). When present in the active conformation, the 
NFoxG 1 :GR526 protein was able to regulate a p-galactosidase reporter plasmid, resulting 
in a characteristic blue colour accumulating in the colonies when cultured on X-gal 
media. When NFoxG 1 :GR526 was inactive, it failed to activate the p-galactosidase 
reporter and colonies remained white. 25.29% of the human NFoxG 1 :GR526 fusion 
proteins switched into an inactive prion-like state, whereas 1.06% of the rat switched 











to the active state, although at a lower percentage than the initial conversion percentage. 
In an alternative assay, these domains were fused to green fluorescent protein (GFP) and 
the solubility of the protein in yeast was observed using fluorescent microscopy. The 
human and rat NFoxG 1 :GFP constructs resulted in both soluble and aggregated GFP in 
vivo. 
Western blot analysis confirmed that the GR526 protein was expressed at similar levels in 
both blue and white colonies. The inactive state of the GR526 protein was found to be 
cured by growth on a protein denaturant, suggesting a prion-like mechanism. The 
NFoxG 1 :GR526 protein extracted from blue colonies was found to sediment at the same 
rate as a control soluble protein on a sucrose gradient, while the protein extracted from 
the white yeast colonies was found to sediment at a much faster rate, typical of 
aggregated proteins. A yeast mating experiment was used to determine whether the 
inactive state of the GR526 protein was transmissible, therefore displaying a prion-like 
mechanism. White and blue yeast colonies transformed with the NFoxG 1 :GR526 
constructs were mated, to determine whether the inactive state of the NFoxG 1 :GR526 
fusion protein was transmissible. The inactive states of the NFoxG 1 :GR526 constructs 
converted active NFoxG 1 :GR526 to an inactive state, demonstrating that the mechanism 
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1. 1. FoxG 1 in early neural development 
Forkhead box 01 (Fox01), previously named Brain factor 1 (BF-1) (Kaestner et al., 2000), 
belongs to the family of HNF-3/ fork head genes, which encode winged-helix transcription 
factors (Lai et al., 1993 and Xuan et al., 1995). This family of transcription factors includes 
fork head, a Drosophila nervous system gene (Weigel et al., 1989), mammalian hepatocyte 
nuclear factors (HNF) 3a, 3p and 3y (Lai et al., 1991), and to date at least 43 members of the 
human FOX gene family (Katoh and Katoh, 2004). This class of transcription factors is 
characterized by the DNA binding domain, containing a conserved 100-amino acid region, 
which folds into three a-helices and two large "wings" (Kaestner et al., 2000), hence the 
name winged-helix. Irregular expression of these genes results in chronic disorders and 
disease. 
1.1.1. Development of the telencephalon 
FoxO 1 is expressed in the olfactory neuroepithelium and the telencephalon of the developing 
forebrain, where it is required for normal development of these structures (Tao and Lai, 1992 
and Xuan et a/., 1995). During the development of the central nervous system the caudal 
section of the neural tube gives rise to the spinal cord, while the rostral gives rise to the brain. 
The brain is initially subdivided into the forebrain, midbrain, and hindbrain. The 
telencephalon arises from the forebrain, and develops from approximately embryonic day 











the cerebral hemispheres, including the cerebral cortex, hippocampus, olfactory bulbs and the 
basal ganglia (Tao and Li, 1992 and Martynoga et ai., 2005). The cerebral neocortex is a six-
layered structure unique to mammalian brains, and absent throughout other vertebrates (Clark 
et ai., 2001). The six layered structure is composed of the ventricular, subventricular, 
intermediate, subplate, cortical plate, and marginal zones, forming the deep to more 
superficial layers respectively (Rakic, 1995). There is huge variation in the surface area of the 
neocortex between mammals, with the human structure displaying an approximate WOO-fold 
increase in comparison to that of the mouse and a ten-fold increase in comparison to that of 
the monkey, while the relative thickness of the structures varies by a factor of two (Fig. 1.1, 
Rakic, 1995, Sultan, 2002). 
The expansion of the surface area of the neocortex is a significant element in the evolution of 
mammals, with advanced cognitive functions evident in those with larger cerebral 
hemispheres (Hill and Walsh, 2005). Expansion of the neocortex relies on the proliferation of 
cortical progenitor cells. These cells undergo symmetrical cell division, thereby increasing the 
number of progenitor cells prior to dividing asymmetrically, giving rise to differentiated 
neurons (Rakic, 1995). The progenitors of cortical neurons are present in the ventricular and 
subventricular zones, and form a pseudostratified epithelial layer. Cajal-Retzius (CR) neurons 
are the earliest born neurons in the development of the cerebral cortex, and are present in the 
outermost layer of the structure. CR neurons originate in the subventricular zone, and form 
the preplate. The preplate is later divided into the marginal zone and the subplate, by the 
neurons forming the cortical plate (Fig. 1.1). Radial glial cells are present throughout the 
layers of the cortex, and it is along these cells that differentiated neurons migrate radially, 











of the subventricular zone form ontogenetic columns in the cortical plate, in which they are 
arranged radially, one above the other. Within the ontogenetic columns the cells are arranged 
according to their arrival date, older cells are present closer to the ventricular zone, and the 
newly arrived cells are present closer to the surface of the structure. The thickness and the 
surface area of the neocortex rely on the length of the columns, and the number of columns 
respectively, both of which are affected by the number of cortical progenitor cells (Molnar et 























Figure 1.1. Differences in the cerebral cortex size are associated with differences in cortex circuitry. The 
cerebral cortex is derived from two developmental cell populations. namely the primordial plexiform layer (PPL) 
or preplate. and those of the cortical plate (CP). The preplate is homologous to the simple cortical structures seen 
in amphibians and reptiles. and develops first in mammalian brain development. As the cortical plate develops. 
the preplate layer is split into layer I (marginal zone) and the subplate (SP). Cortical plate layers develop from 
the deeper layers first. to the superficial last. In mammalian brains. the cortical plate layers are elaborated in 
those with increased cognitive function. the human cortical plate layers II and III are subdivided into lIa, lIb, and 
I1Ia-I1Ic respectively. while in rodents the layers II and III make up a single layer. Taken from Hill and Walsh. 
2005. 
1.1.2. Characterization of FoxGl 
FoxG 1 was originally identified in the screenmg of a rat adult brain cDNA library with a 











fetal rat brain, with a four fold increase in E 17 in comparison to the adult tissue. In situ 
hybridization studies revealed the transcription factor was expressed in the ventricular zone of 
the cortex, hippocampus and olfactory bulb, as well as the olfactory epithelium. FoxG 1 was 
later shown to be expressed in the optic chiasm (Pratt et aI., 2004). The human and mouse 
homologues was consequently cloned using a rat derived probe in the same manner (Li et aI., 
1996, Murphy et ai., 1994). FoxG1 orthologues were subsequently identified in zebrafish and 
the chordate, amphioxus. FoxG 1 was expressed in the anterior neural tube of these organisms, 
a similar pattern seen in other vertebrates (Toresson et al., 1998). 
In order to investigate the role of FoxG 1 in brain development, transgenic mIce were 
produced in which the FoxG 1 gene was deleted through a null mutation (Xuan et aI., 1995). 
At E9.5, when compared to wildtype embryos, homozygous null mutants displayed minimal 
differences in the size of the telencephalon. However, by E10.5 and E12.5 a vast reduction in 
the size of the telencephalon was apparent, and at birth the cerebral hemispheres of the 
mutants were reduced by 95% in mass. Bromodeoxyuridine (BrdU), used to label 
proliferating cells, revealed that the reduction in size of the telencephalon was a result of the 
early depletion of the progenitor cell population. Premature onset of neuronal differentiation, 
assayed by the expression of microtubule-associated protein 2 (MAP2) in postmitotic 
neurons, was also apparent. In wildtype embryos (E12.5) MAP2 positive cells were restricted 
to a thin layer of cells on the outer layer of the ventricular zone, made up of the earliest born 
neurons. Mutant embryos however displayed a thickening of this layer as a consequence of an 
increase in the number of neural progenitor cells exiting the cell cycle and differentiating into 











proliferation of progenitor cells III the telencephalon, and preventing their premature 
differentiation into neurons. 
Hanashima et al. (2004) confirmed these results by examining the effect of FoxG 1 on Cajal-
Retzius neurons in mice. In the E 18.5 cortex of FoxG 1 mutants CR neurons were found to be 
in excess when compared to wildtype embryos. The cells were visualized with the use of 
reelin, a CR marker. These results suggest that FoxG 1 functions to suppress the excess 
production of CR neurons after their normal birthdate, and thus plays an important role in the 
regulation of differentiation, and the development of the six-layered cerebral cortex. 
1.1.2.1. The function of FoxG 1 differs in the dorsal and ventral telencephalon 
Xuan et at. (1995) showed that in FoxG 1 mutant embryos the dorsal telencephalon was not 
affected as severely as the ventral region at E12.5. The dorsal telencephalon gives rise to the 
cerebral cortex, while the ventral develops into the ganglionic eminences, the primordia of the 
basal ganglia. The ganglionic eminences, present in wildtype embryos at E12.5, were absent 
in the mutants at the same embryonic stage, and the ventral region did not display any 
markers typical of the region. At E12.5 the dorsal telencephalon was present more ventrally in 
the mutant embryos, and was reduced in size. They suggested that the absence of the ventral 
structures was a result of the lack of proliferating precursor cells in the region after E9.5, and 
that role of FoxG 1 in proliferation was uniform across the telencephalon. The authors did not 
however reject the possibility that the role of the transcription factor in the ventral region of 











Martynoga et al. (2005) established that the role of FoxG 1 differs in the ventral 
telencephalon, by studying cell cycle kinetics in the telencephalon of mutant embryos. At 
E 10.5 there is a more severe slowing of the proliferation rate of progenitor cells in the dorsal 
region of the mutant embryos in comparison to the wildtype, in agreement with Xuan et al. 
(1995). The cells in the ventral region, however, were seen to proliferate at the same rate as 
those cells in the wildtype embryos. The authors were also unable to visualize any gene 
markers characteristic of the ventral region, confirming results originally described in Xuan et 
al. (1995). Martynoga et al. (2005) concluded that FoxG 1 is required for specification of the 
ventral telencephalon, as in the absence of the transcription factor it fails to develop. These 
results suggest that while FoxG 1 controls proliferation and differentiation in the dorsal 
telencephalon, it is required for correct patterning of the ventral telencephalon. 
The hypothesis that FoxG 1 temporally regulates differentiation and proliferation in the dorsal 
region of the telencephalon has been criticized by other researchers. Muzio and Mallamaci 
(2005) have argued that FoxG 1 regulates patterning in the dorsal telencephalon, as well as the 
ventral. The authors interpret the excess number of CR neurons in FoxG 1 mutant mouse 
embryos (Hanashima et al. 2004) as a repatterning of the region, opposed to a lack of 
repression of differentiation by FoxG 1. It is suggested that the neocortical plate in FoxG 1 
mutants is absent, and is replaced by the more caudal hippocampal plate. The authors believe 
that FoxG 1 is required for the repression of the development of the hippocampus, and is an 
important repressor in dorso-medial patterning. It was noted that in FoxG 1 mutant embryos a 
true hippocampal plate failed to develop and thus further research is required to determine the 











1.1.2.2. FoxG 1 acts in a dosage dependent manner 
Ectopic expression of XFoxG 1 (Xenopus laevis FoxG 1 mRNA) in the posterior neural plate of 
Xenopus embryos provided further insight into the role of FoxG 1 in the development of the 
telencephalon (Bourguignon et aI., 1998). When injected with high concentrations (0.5 ng) of 
synthetic XFoxGl RNA, proliferation of the neural progenitor cells in the injected area was 
evident, with a concomitant lack of expression of N-tubulin, a neuronal differentiation 
marker. These embryos did however; exhibit signs of differentiation in the adjacent tissue. 
Interestingly, when injected with low concentrations (90 pg) of the Xenopus mRNA, neural 
progenitor cells in the injected area were seen to differentiate, and were no longer in a state of 
division. The results suggest that FoxG 1 acts as both a repressor and activator of 
neurogenesis, in a dosage-dependent manner: stimulating proliferation at high concentrations 
and inhibiting neuronal differentiation, and promoting differentiation when present in low 
concentrations. These results make possible the idea that FoxG 1 acts in a gradient-related 
manner during the development of the telencephalon, an idea also expressed by Muzio and 
Mallamaci (2005). 
1.1.3. FoxGl acts as both a transcriptional repressor and activator 
Qin, the chicken orthologue of FoxG 1, was isolated from the avian sarcoma virus 31, found in 
spontaneous connective tissue tumours in adult chickens (Li and Vogt, 1993, Li et al., 1995, 
Li et al., 1997). Qin acts as a transcriptional repressor, suggesting that FoxG 1 might have a 
similar function. In order to determine whether FoxG 1 acts as a transcriptional repressor or 
activator Bourguignon et al. (1998) fused XFoxG 1 to a strong repressor domain, EnR, derived 
from the Drosophila Engrailed protein. Independently, XFoxG 1 was fused to a strong 











mRNA from the construct containing the activator, or repressor, and the results of the ectopic 
expression were compared to those obtained from injecting the wildtype XFoxG 1. If FoxG 1 
acts as a transcriptional repressor, or activator, the authors anticipated that one of the 
experimental transcripts would mimic the wildtype mRNA, and the other would show the 
opposite affect. The development of the embryos injected with XFoxGl-EnR was almost 
identical to that of the embryos injected with the wildtype mRNA. Embryos injected with 
XFoxGl-E1A showed similar development to those injected with the wildtype mRNA, but 
were less similar than the XFoxGl-EnR injected samples. These results suggest that FoxG 1 
acts as both a repressor and activator of transcription. 
Hardcastle and Papalopulu (2000) showed that XFoxG 1 suppresses expression of p27x1C1 , a 
cyclin-dependent kinase (cdk) inhibitor, which is normally expressed in non-dividing cells 
and regulates cell cycle. It is through this inhibitor that the transcription factor seems to affect 
cell proliferation. The authors found that p27x1C1 is suppressed by high FoxG 1 concentrations 
at the mRNA level, and in the absence of protein synthesis, while low concentrations of 
FoxG 1 were seen to induce expression. It was also found that injecting p27x1C1 into Xenopus 
embryos blocked the cell cycle, but was not sufficient to induce expression of N-tubulin, a 
result of the injection of XFoxGl. These results imply that the regulation of cell proliferation 
by FoxG 1 is mediated through p27x1C1 , while cell fate is regulated in a different manner. 
1.1.3.1. In order to repress transcription, FoxG 1 interacts with GrouchoffLE and Hes 
The mammalian transcriptional co-repressor Transducin-like Enhancer (TLE) 1 is 
homologous to the Drosophila Groucho (Gro), which represses neuronal differentiation 











interacts with HairylEnhancer of Split (Hes) to form complexes which inhibit the expression 
of prone ural genes, positive regulators of neuronal differentiation. In these complexes the Hes 
proteins fulfill the DNA binding function, and Groucho acts as a transcriptional repressor. 
This mechanism of repression by GroffLE and Hes is conserved in invertebrates and 
vertebrates. In 2001 Yao et al. showed that FoxG 1 interacts with GroffLE 1 and Hes. The 
authors showed that FoxG 1 was capable of forming complexes with Gro/TLE 1, which both 
included, and excluded Hes. In the latter complex the FoxG 1 protein itself provided the DNA 
binding domain. FoxGl did not form complexes with Hes, independently of Groff LEI, 
suggesting that GroffLE 1 is required as an adaptor for the interaction between the two. It is 
thought that through the formation of these complexes FoxG 1 is able to repress neuronal 
differentiation. FoxG 1 was found to recruit histone deacetylase (HDAC) 1, and when 
inhibited by trichostatin A, a decrease in repression of proneural genes by FoxG 1 was noted. 
Histone deactylases have previously been shown to interact with GroffLE proteins. More 
recently Marc;al et al. (2005) demonstrated that the newly identified Gro/TLE-related gene 
product 6 (Grg6) may be involved in the regulation of neurogenesis. Grg6 inhibits 
interactions between FoxG 1 and GroffLE, therefore suppressing repression of proneural 
genes by the complex, and is required for neuronal differentiation. 
1.1.3.2. FoxGl disrupts the TGF-p signaling pathway 
FoxG 1 has also been shown to disrupt the ~-type transforming growth factor (TGF-~) 
signaling pathway (Pelton et al., 1991). TGF-~ proteins are secreted growth factors that are 
involved in organogenesis and morphogenesis in the developing embryo. Their functions 
include, amongst others: regulation of differentiation, extracellular matrix deposition and 











TGF- P2 and 3 were expressed strongly in the developing brain and central nervous system, 
where they are believed to regulate proliferation of neuronal progenitor cells. In the TGF-p 
signaling pathways the TGF-p ligand binds to the outer surface of the cell via a complex of 
type I and II receptor kinases. In response to ligand binding, type I receptor kinases are 
phosphorylated by the type II TGF-p receptors, which in turn phosphorylate specific Smad 
proteins (2 and 3). The phosphorylated Smad protein associates with Smad4 forming a 
complex which is translocated into the nucleus. In the nucleus the Smad complex is able to 
regulate transcription of target genes, through the interaction with DNA-binding transcription 
factors (Smad binding partners) (Derynck and Zhang, 2003). In 2000, Dou et al. showed that 
FoxG 1 associates with the Smad binding partner FoxH2, which is required by the Smad2/3/4 
complex to bind DNA. Rodriguez et ai. (2001) subsequently demonstrated that FoxGl was 
also able to bind the Smad proteins themselves, preventing the formation of the Smad2/3/4 
complex. The carboxyl-terminus of FoxG 1 was found to be exclusively required for this 
means of disruption. Furthermore, Seoane et al. (2004) showed that FoxO proteins are key 
partners in the TGF- P pathway, resulting in transcriptional activation of p21 Cipl, a cdk 
which represses growth-promoting transcription factors. FoxG 1 was shown to associate with 
Fox03 or Smad3/4 in this pathway, disrupting it. Thus, FoxG 1 inhibits neuronal 
differentiation by associating with GrolTLE and Hes, and promotes proliferation by 
disrupting the TGF- P pathways, which would ordinarily repress the cell cycle. 
1.1.3.3. BMP4 and FGF-8 may be regulated by FoxGl 
Bone morphogenic protein (BMP) 4 belongs to the TGF-p superfamily and has shown to be 
required for neuronal differentiation and the repression of progenitor cell proliferation (Li et 











superfamily, but make use of specific BMF-ligand transmembrane receptors, and activate 
Smads 1,5 and 8 (Derynck and Zhang, 2003). In 1999, Dou et al. showed that by E10.5 in 
mice embryos, BMP4 is expressed in a pattern complementary to that of FoxG 1, BMP4 is 
localized to the dorsomedial telencephalon and the roof of the telencephalon. The authors 
suggested that FoxG 1 might repress BMP4 and hence examined the expression patterns of 
BMP4 in FoxG 1 null mutant embryos. By E11.5 in mutant embryos, BMP4 was visualized in 
the entirety of the dorsal telencephalic neuroepithelium, indicating the expansion of the 
domain of expression. These results suggest that FoxG 1 is required for the down-regulation of 
BMP4 in certain areas of the developing telencephalon. Similarly, Hanashima et al. (2002) 
showed that the regions of expression of BMP6, 7 and 2 are also expanded in the 
telencephalon of FoxG 1 mutant mice. With the use of a FoxG 1 DNA-binding domain mutant, 
the authors demonstrated that this domain is required for the down-regulation of BMPs, 
resulting in the repression of neuronal differentiation. It was also noted that stimulation of 
proliferation by FoxG 1 was independent of the DNA-binding domain, indicating that control 
of proliferation and neuronal differentiation are mediated independently. 
A second growth factor, fibroblast growth factor (FGF)-8, is also believed to be regulated by 
FoxG 1. FGF8 is required for the continued proliferation of precursor cells, and is an inhibitor 
of neurogenesis in the midbrain, where it is expressed in the rostral metencephalon (Lee et al., 
1997). Fukuchi-Shimogori and Grove (2001) showed that FGF8 is required for rostro-caudal 
patterning of the telencephalon, where it displays similar functions. Martynoga et al. (2005) 
have demonstrated that there is a marked reduction in the expression of FGF8 in ElO.5 
FoxG 1 mutant mice embryos, when compared to wildtype embryos. However at E9.5, Fgf8 











embryos. This reduction in expressIOn at E 1 0.5 coincided with the decreased rate of 
proliferation in the rostral telencephalon, indicating that FoxG 1 might upregulate FGF8 
expression and maintain progenitor cells in a proliferative state. 
1.1.4. FoxGl is comprised of three distinct domains: the N-terminus, the DNA-binding 
domain and the C-terminus 
The cloning of various FoxG 1 orthologues from vertebrates, including reptiles, fish, birds and 
mammals, has revealed that both the DNA-binding and the carboxy (C)-terminal domains are 
almost identical, while there is considerable variation evident in the N-terminal domain of the 
transcription factor (Bredenkamp et ai., 2006). The DNA-binding domains of the orthologues 
all contain the 100-amino acid region characteristic of the winged-helix family (Kaestner et 
al., 2000), while the C-terminal domains contain a conserved 211 amino acid region. FoxG 1 
is grouped into class 1 of the FOX proteins, because of the basic C-terminal region typical of 
this class (Katoh and Katoh, 2004). 
As previously discussed, Yao et ai. (2001) showed that the DNA-binding domain of FoxGl 
was required for the repression of proneural genes by the Groff LEI complex. The domain 
was also shown to be necessary for the down-regulation of BMPs, and the subsequent 
repression of neuronal differentiation (Hanashima et ai., 2002). The C-terminal domain of 
FoxG 1 was shown to be required for binding to the Smad proteins, or Smad binding partners, 
leading to the disruption of the TGF-~ pathway, and promoting proliferation (Dou et ai., 
2000, Rodriguez et ai., 2001, and Seoane et al., 2004). The high levels of conservation in 











The N-terminal domains of FoxG 1 orthologues share a common sequence in the first 30 
amino acid residues, including a predicted Casein kinase 1 phosphorylation site, which has 
been shown necessary for FoxG 1 nuclear localization (Regad et al., 2006), after which the 
domain is significantly different. The N-terminal domains of mammalian orthologues are of 
particular interest; these contain significant quantities of histidine (H), proline (P) and 
glutamine (Q) amino acid residues (Tao and Lai, 1992, and Bourguignon et al., 1998), while 
these expanded domains are severely reduced in the FoxG I orthologues of other vertebrate 
species, such as that of Xenopus and zebrafish (Fig. 1.2). 
HUMAN MLDMGDRKEVKMIPKSSFSINSLVPEAVQNDNHHASH.GHHNSHHPQHHHHHHHHHHHPP 59 
RAT MLDMGDRKEVKMIPKSSFSINSLVPEAVQNDNHHASH.GHHNSHHPQHHHHHHHHHH.PP 58 
MOUSE MLDMGDRKEVKMIPKSSFSINSLVPEAVQNDNHHASH.GHHNSHHPQHHHHHHHHHH.PP 58 
CHICKEN MLDMGDRKEVKMLPKSSFSINSLVPEAVQSDNHS.GH.SHHNSHHPHHHHHHHHHH .. PP 56 
XENOPUS MLDMGDRKEVKMIPKSSFSINSLMPEAVQNDNHPQPHHHHHHQQQPQHLQLPQQHHL.QP 59 
ZEBRAFISH MLDMGERKEVKMIPKSSFSINSLVPEAVQSDNHH .... HHHHQQQ.Q ....... HHH. . . 45 
xx xx x xxx 
HUMAN PPAPQPPPPPQQQQPPPPPPPAPQPPQTRGAPAADD .. DKGPQQLLLPPPPPPPPAAALD 117 
RAT PPAPQPPPPPPQQQQQ .. PPPAPQPPQARGAPAADD .. DKGPQPLLLPP ...... SAALD 108 
MOUSE PPAPQPPPPPPQQQQQQ.PPPAPQPPQARGAPAADD .. DKGPQPLLLPP ...... STALD 109 
CHICKEN PP ......... QQ ......... PQ .... RAAAAEEEDEEK .. APLLLPPPAA .... GALE 88 
XENOPUS HH .......................... RPLQ.EEDELDK ... SLL ............. E 76 
ZEBRAFISH ............................ RTVH.EEEE .. K .. TPLPAQVQ ......... E 63 




CHICKEN .AAKAEALA.GKGEAGAA.AAEL ..... EEKEK .... AAEEKKGAAEGGK 
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Figure 1.2. Amino acid alignment of the N-terminal domains of various FoxGI orthologues. The 
mammalian orthologues contain the expanded H/P/Q rich domain (solid line below sequence). which is reduced 
in other orthologues such as chicken, and Xenopus. Thc cxcess proline residues present in the human and absent 
in the lower mammals. such as rat. are underlined in red. Large numbers of glycine and alanine amino acid 
residues are present downstream of this expanded region in the mammalian orthologues (x. above sequence). 











While a stretch of histidine residues is present in all of the orthologues, the mammalian 
orthologues include a stretch of 17-21 proline amino acid residues (Bredenkamp et al., 2006, 
Fig. 1.2). The N-terminal domains of the mammalian orthologues also contain large numbers 
of glycine (G) and alanine (A) amino acid residues. 
The presence of the expanded HlP/Q-rich domain in mammalian orthologues, similar to the 
expanded domains and amino acid repeats seen frequently in the N-terminal domains of prion 
proteins (Lindquist, 1997 & Shorter and Lindquist, 2005), has raised an interesting question: 
does this domain act as a prion-like switch, inducing a conformational change and 
aggregation of the FoxG 1 protein, thereby regulating its activity during neuronal 
development? 
1.2. Prions: proteins capable of infectious amyloid formation 
Prions are widely believed to be infectious proteins capable of self-perpetuating changes in 
conformation, with the prion form of the protein acting as a self-replicating agent (Shorter and 
Lindquist, 2005). The term "prion" is derived from "proteinaceous infectious particle", and 
the concept began with the study of various mammalian neurodegenerative diseases (Prusiner, 
1982). These include: Creutzfeldt-lakob disease (C1D), Gerstmann-Straussler-Scheinker 
(GSS) syndrome, Fatal Sporadic Insomnia (FSI), and kuru in man, scrapie in sheep, and 
bovine spongiform encephalopathy (BSE) (Prusiner, 1982 and 1998). Prion particles are 
believed to form ordered aggregates under physiological conditions, and are devoid of nucleic 
acids. Prions are sensitive to protein denaturing agents, such as proteases and acidic sodium 
dodecyl sulfate (SDS), and are unaffected by exposure to UV radiation and other nucleic acid-











1.2.1. Mammalian prion diseases 
The abovementioned mammalian diseases all have in common a conversion of the prion 
protein PrP, which is normally expressed in mammalian cells. Spongiform encephalopathies 
result when the cellular form of the protein, Prpc, is converted into the insoluble prion form, 
Prpsc • PrP is a plasma membrane anchored glycoprotein, expressed in the developing and 
mature central nervous system, although not essential for normal development (Steele et al., 
2006). Steele et al. (2006) found that Prpc expression was strongest in fully differentiated, 
mature neurons, and lowest in multi potent neuronal precursors. Prpc increases cellular 
proliferation in the subventricular zone (SVZ) of the mammalian central nervous system, a 
region containing multi potent precursor cells. In humans, more than 20 different mutations of 
the PrP gene are known to cause inherited prion diseases, while how sporadic disease occurs 
is largely unknown (Prusiner, 1991 and 1998). 
Brandner et al. (1996) demonstrated that the Prpc protein is necessary for the development of 
scrapie. Embryonic telencephalic tissue from mice over-expressing PrP was grafted onto brain 
tissue of PrP null mutant mice (Pm_liD), while simultaneously injecting the tissue with 
scrapie prion particles. Similarly, deficient brain tissue was engrafted with wildtype tissue and 
that of the mutants, and injected with the prion particles. The authors found that grafting the 
PrP over-expressing tissue to the brain resulted in the development of scrapie after 70 days, 
while grafting wildtype tissue resulted in the development of the disease at 160 days. The 
Pm_liD host, engrafted with the deficient telencephalic tissue, did not display any 
pathological signs of scrapie. Thus, in the development of prion diseases, Prpc is necessary for 











1.2.2. Yeast prions are non-pathogenic, heritable phenotypes 
Three prions have been found in the yeast Saccharomyces cerevisiae. These prion states, 
namely [URE3] , [PS]+] and [RNQl] are able to produce heritable changes in phenotype, 
without a change in nucleic acid sequence, and are a determined by the genes encoding 
Ure2p, Sup35 and Rnql respectively (Chernoff et ai., 1995, Sondheimer et ai., 2001, Ter-
Avanesyan et ai., 1994 and Wickner, 1994). Yeast prions are non-pathogenic and are 
transmissible between mating cell types, displaying non-Mendelian patterns of inheritance 
when passed on to daughter cells. 
Yeast prions generally share no sequence homology to other prions, or to each other, but do 
share a number of structural traits (Lindquist, 1997, and Sondheimer et ai., 2001). The N-
terminal domains are usually dispensable for their cellular function, but are required for prion 
accumulation; these domains are also often rich in glutamine (Q), asparagine (N) and other 
polar amino acid residues, including oligopeptide repeat sequences, and often display 
conformational flexibility (Derkatch et at., 2004). Interestingly, it is the C-terminal domain of 
the yeast prion Rnq 1 which is intrinsically unstructured. Similarly, the N-terminal domain of 
the mammalian PrP protein contains regions (amino acid residues 1-103) of conformational 
flexibility, and while the amino acid sequence is not QIN-rich, it does contain oligopeptide 
repeats (Shorter and Lindquist, 2005). 
1.2.3. Formation of amyloid fibres 
A feature shared by both mammalian and yeast prion proteins is the ability to form amyloid 
fibres in vitro and in vivo (Govaerts et at., 2004, Krishnan and Lindquist, 2005, and Scheibel 











diameter, with ~-pleated sheet conformation. They display a greater resistance to proteases 
and detergents than soluble proteins and bind the dyes Congo Red and Thioflavin T and S 
(Shorter and Lindquist, 2005). Different prion strains of the same protein have been 
identified, which differ in the structure and size of the prion fibres. In yeast, the Sup35 protein 
forms ~-rich amyloid fibres. Fibres formed by the N-terminal domain (NM) have been 
extensively studied to further understand the formation of amyloids in general (Krishnan and 
Lindquist, 2005). The authors found two regions within the NM domain that formed 
intermolecular contacts during fibre formation, the "head" region (residues 25-38), and the 
"tail" region (residues 91-106). The residues (43-85) between these regions were referred to 
as the "central core", and did not contribute to intermolecular contacts. They demonstrated 
that the contacts between individual NM proteins occurred in a "head-to-head" and "tail-to-
tail" manner, and that the residues forming the amyloid core rapidly entered an unstructured 
molten form, prior to fibre formation. 
Krishnan and Lindquist (2005) suggested that in this molten state the "head" regions initially 
come into contact, in what seems to be a lag phase in fibre formation. Following formation of 
this nucleus, the "tail" regions form intermolecular contacts. These contacts result in the 
formation of fibrils, which form bi-directionally by recruiting additional proteins; fibrils are 
then connected in some manner to form prion fibres (Fig. 1.3). The C-terminus of the NM 
protein was found to be excluded from the fibril formation, and remains unstructured. The 
authors also noted that a change in the intermolecular contacts produced different prion 
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produced in Escherichia co ii, disease is induced (Legname et ai., 2004). Injection with 
soluble proteins had no such effect. Similarly, when transgenic mice over-expressing the GSS 
syndrome-associated PrP P101L mutation, were injected with synthetic PrP P101L folded 
into a p-rich conformation, GSS syndrome was induced (Tremblay et ai., 2004). Saa et al. 
(2006), recently developed Protein Misfolding Cyclic Amplification (PMCA) technology, a 
technique used in vitro to amplify Prpsc aggregates in a cyclic manner similar to PCR. Small 
quantities of Prpsc aggregates are incubated with Prpc, resulting in the formation of large 
aggregates which can be broken into smaller fragments by sonication, and are self-
perpetuating. When injected into wildtype hamsters, these aggregates induced disease in the 
same manner as prions purified from scrapie infected brain tissue. 
1.2.5. Regulation of yeast prions 
In yeast, the conformational switching seen in prions is a novel method of post-translational 
control, and is not a disease state. Prion aggregation is regulated by chaperone proteins. It has 
been shown that expression of the chaperone Hsp104 is necessary for all three prion states to 
exist (Chernoff et ai., 1995, Moriyama et ai., 2000, and Sondheimer et ai., 2001), and 
determines inheritance of the prion state. Chaperones are proteins which assist in the folding 
of other proteins, by preventing aggregation of unfolded forms. Over-expression or 
inactivation of Hsp104 causes curing of the [PSr] phenotype, thus an intermediate level of 
the chaperone is required for prion formation and maintenance (Chernoff et al., 1995). 
Another yeast chaperone has been identified, which specifically regulates [RNQ+] 
(Sondheimer et ai., 2001). Sis1, a member of the Hsp40 family, co-immunoprecipitates with 











essential for the formation of the prion fibres. Similar chaperones have not been identified in 
mammals. 
1.2.6. Prions in memory formation 
Prion fibre formation is not restricted to proteins involved in disease, or to yeast; a neuronal 
isoform of the Aplysia cytoplasmic polyadenylation element binding (CPEB) protein has been 
found to have prion-like properties (Si et ai, 2003). CPEB acts as both an activator and 
repressor of dormant mRNA translation. In order to activate dormant mRNA, CPEB 
elongates the poly(A) tails of target molecules. The neuronal isoform of the Aplysia CPEB 
protein lacks phosphorylation sites. The authors noted the similarities between the N-terminal 
domain and the same region of the known yeast prions; the ApCPEB N-terminus contains a 
high number of glutamine amino acid residues, including six repeats, and shows 
conformational flexibility. The authors demonstrated that not only did the ApCPEB protein 
contain prion-like properties, but that the self-perpetuating prion form of the protein is the 
active form, able to bind to and activate dormant mRNAs. CPEB is translated at particular 
synapses in response to neurotransmitters (serotonin in Aplysia) and it is suggested that the 
prion form of the protein accumulates as a result of this trigger, to facilitate long-term 
memories at these specific synapses. As the turn-over of the prion form of proteins is reduced 
in comparison to the soluble form, the active form of ApCPEB might be able to maintain 
long-term changes in mRNA translation at specific synapses, in response to serotonin as a 
physiological signal. It is suggested by the authors that this mode of action may be used by 











1.2.7. Prions vs. amyloids: when is an amyloid a prion? 
Although prions are proteins capable of forming self-perpetuating amyloid fibres, not all 
naturally occurring protein amyloid fibres are a result of prions. The formation of amyloid 
fibres is seen in various non-prion diseases, including Alzheimer disease (AD), Parkinson 
disease (PD), Huntington disease and type II diabetes (Dobson, 2003). In E. coli, the 
extracellular Curli protein forms amyloid fibres that are involved in colonization of inert 
surfaces, biofilm formation and binding to host proteins, but it is not considered a prion 
(Chapman et ai., 2002). These amyloid fibres, like those of prions, are ~-rich, with the ~­
strands running perpendicular to the fibril axis. What distinguishes prions from non-prion 
amyloids is their transmissibility (or infectivity) to uninfected cells and tissue. The absence of 
transmissibility may result from many factors. In the case of Prpsc (a mammalian prion) 
infectivity can occur via the food chain, as the prion aggregates are resistant to proteases in 
the mammalian gut the disease is transmitted between species (Shorter and Lindquist, 2005). 
It is possible that the non-transmissibility of non-prion amyloids is a result of the lack of a 
similarly successful mechanism. It is also possible that in non-transmissible amyloids a 
difference in amino-acid residue use prevents cross-species transmission, a barrier not 
restricting prions. Work on yeast prions has revealed that the accumulation of short amyloid 
fibres is more successful at both changing the phenotype of the host, and in transmitting the 
prion. It seems that a greater number of short fibres release more self-replicating fibre ends, 
which are transmitted between mating cells and to offspring. It is possible that non-prion 
amyloid fibres have increased fibre length, decreasing the rate of possible transmissibility. 
The infectivity of a protein displaying prion-like properties can easily be investigated, 
allowing researchers to determine whether the protein is able to form non-prion amyloids, or 











1.2.8. Investigating possible prion-like properties of proteins 
Two assays have been developed to investigate whether proteins display prion-like properties. 
Originally designed to study yeast prions, these assays have been used successfully to 
investigate other proteins, such as the Aplysia CPEB protein (Si et ai, 2003). The assays rely 
on the ability of prions to confer upon other proteins a change in conformational state. 
Suspected prion domains can be fused to a glucocorticoid receptor (GR526) construct, and the 
functionality of the construct in yeast cells determined (Li and Lindquist, 2000). Similarly, 
suspected prions can be visualized when fused to green fluorescent protein (GFP), and the 
ability of the protein to aggregate can be investigated via fluorescent microscopy (Patino et 
aI., 1996). 
1.3. Research aims 
In this research dissertation, I have used these assays to investigate whether the N-terminal 
domain of FoxG 1 has prion-like properties. I have compared the prion-like properties of the 
human and rat orthologues. These orthologues have been specifically chosen to determine 
whether any prion-like properties are dependent on the length of the expanded HlP/Q-rich 
domain present in the N-terminus of the transcription factor, and whether prion-like properties 
are functionally different between mammals with large (human) and small (rat) cerebral 
hemispheres. The ability of the N-terminal domains to form aggregates with GFP, and confer 
upon the GR protein an ability to change conformation was examined. In order to determine 
whether the prion-like state was a result of a prion, or a non-prion amyloid, heritability of the 













The N-terminal domains of rat and human FoxGl can confer upon other proteins 
a change in conformation 
2.1. Introduction 
The N -terminal domains (NFoxG 1) of mammalian FoxG 1 (or BF-l) orthologues are of 
particular interest, due to the expanded HlP/Q-rich domain. Similar tracts of amino acid 
residues are often present in prion proteins. In this research dissertation, I have tested the 
hypothesis that the N-termini of FoxG 1 orthologues have prion-like properties, enabling the 
FoxG 1 protein to change conformation, and exist in both ordered aggregates and in a soluble 
state. The prion-like properties of NFoxG 1 of the rat and human orthologues were compared 
with the use of yeast assays. 
The yeast prion determinant Sup35 has been used to establish whether prions are able to 
impose upon other proteins the ability to change their conformational state (Li and Lindquist, 
2000). The N-terminal domain of Sup35 (NM domain), which is necessary for prion fibre 
formation, was fused to a constitutively active rat glucocorticoid receptor (GR526). A GR526_ 
regulated ~-galactosidase reporter plasmid was co-transformed into yeast cells and the colour 
of the colonies was used to determine the conformational state of the GR526 protein. When 
GR526 proteins were in their active, native conformation, yeast colonies plated on X-gal media 
acquired a blue colour. The Sup35 NM domain was able to confer upon the GR526 protein an 
alternative conformation, rendering it inactive. As the inactive protein was unable to activate 
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cells when plated on X-gal media was recorded (Fig. 2.2). The pGI_NMGR526 construct was 
used as a positive prion control, while the pG I_GR526 plasmid was used a GR526 control (i.e. 
negative prion control), in the assay summarized in Fig. 2.2. 
An additional assay used to investigate the ability of prion-like proteins to form aggregates, 
has been developed using the Sup35 NM domain and green fluorescent protein (GFP) (Patino 
et ai, 1996). The Sup35 NM domain was fused to GFP and transformed into yeast cells. 
Fluorescent microscopy revealed that the Sup35 NM domain induced GFP to adopt either its 
native, soluble form, or an insoluble form. When Sup35 was present in the prion state, both 
small and large aggregates were visible. 
This assay was used to determine whether the human and rat NFoxG 1 domains were similarly 
able to form aggregates in vivo. The NFoxG 1 domains were fused in frame to GFP, in the 
plasmid p2IlGFP, producing rat (p21l-rBFIGFP) and human (p21l-hBFIGFP) constructs, 
which were transformed into yeast. Fluorescent microscopy was used to view the transformed 
yeast cells and to determine whether the presence of the NFoxG 1 domains resulted in GFP 
aggregation. The plasmid p21lGFP was used as a GFP control, resulting in soluble GFP in 
vivo, and the human and rat NFoxG 1 constructs were examined for signs of either small or 
large GFP aggregation. 
2.2. Materials and methods 
2.2.1. Analysis of secondary structure of FoxG 1 orthologues 
The amino acid composition of Xenopus, rat and human FoxG 1 were used to determine 











of prion proteins. The IUPred server (http://iupred.enzim.hu/) was used to estimate which 
regions in the amino acid content were unstructured, and those which are folded into 
predictable secondary structure (Dosztanyi et ai., 2005). 
2.2.2. peR amplification of FoxG 1 orthologues 
The cloning strategy to subclone the N-terminal domains of the FoxG 1 (BF-1) orthologues 
upstream of GR526 for the prion assay is summarized in Fig. 2.3. For cloning into the pG 1-
NMGR526 plasmid (Table 2.1), the NFoxG 1 domains of the human and rat orthologues were 
amplified by Polymerase Chain Reaction (PCR), from the plasmids pGEM-T easy:hBFl and 
pC52:rBF1 respectively (Table 2.1). The region was amplified from each orthologue using 
FoxG 1 specific primers: BF-l-BamH 1 forward and BF-1-SacII reverse primers, BamH 1 and 
SacII restriction enzyme sites were constructed on the 5' and 3' ends respectively (Table 
2.2.). Approximately 100 ng of vector was used as a template in the following 20 ul reaction 
mix: 1.225 U Expand High Fidelity Enzyme Mix (Roche), 1 X Expand High Fidelity MgCb 
Buffer, 0.25 mM dNTPs, 0.5 JlM of each primer, and 1.2 M betaine. Betaine (N,N,N-
trimethylglycine) was added to the reaction mix to destabilize secondary structure that results 
from the high GC content of the FoxG 1 orthologues (Bredenkamp et ai., 2006, Henke et al., 
1997). Cycling conditions were as follows: 94°C for 3 minutes (1 cycle), 94°C for 30 
seconds, 45°C for 30 seconds, 72°C for 1 minute (5 cycles), 94°C for 30 seconds, 57.5 °C 
for 30 seconds, 72°C for 1 minute (5 cycles), 94°C for 30 seconds, 66.5 °C for 30 seconds, 
72°C for 1 minute (25 cycles) and 72 °C for 7 minutes (1 cycle). 
For cloning into the p2JlGFP plasmid (Table 2.1), the N-terminal domains of human and rat 











Table 2.1. Plasmids used for the glucocorticoid receptor and GFP assays, including sources and 
references. 
Plasmid name Source Reference 
pGI_GR526 Addgene plasmid 1124 Li et al., 2000 
pGI-NMGR526 Addgene plasmid 1122 Li et al., 2000 
pL2/GZ Addgene plasmid 1282 Kimura et al., 1999 
p2f.lGFP Addgene plasmid 1195 Patino et al., 1996 
pGEM-T easy:hBFl N. IlIing Lab Bredenkamp et al., 2006 
pCS2:rBFl N. Papalopulu Lab (gift) N/A 
Table note: Addgene plasmids available from www.addgene.org. 
Table 2.2. Primers used for amplification of the N-terminal domains of FoxGl orthologues, and screening 
of the resulting constructs. 
Primer name Primer sequence (5' - 3') 
BF-I-BamHl fwd. CGG ATC CTC GAT GCT GGA CAT GGG 66.9 
BF-l-SacII rvs. ATC CGC GGA TAC CCG TC(C/T) TTG CCG 70.2/68.6 
BF-I-BamHI rvs. ATG GAT CCA TAC CCG TC(C/T) TTG CCG 66.1164.6 
GR'i26 'fi - speC! 1C rvs. CAC ATT GCT TGT GGA GCC TIT CG 62.9 
GFP specific rvs. AAG TTC TTC TCC TTT ACT CAT ATG GG 58.4 
Table notes: all primers used in the study were designed during the research project, using DNAman (Lynnon Corporation), 
and T m (melting temperature) was calculated using nearest neighbour thermodynamic methods (Breslauer et ai., 1986). 
Restriction enzyme recognition sites are underlined. Degenerate bases are shown in brackets. 
restriction enzyme sites on both the 3' and 5' ends. The following primers were used: BF-l-
BamHl forward and BF-I-BamHl reverse (Table 2.2). Cycling conditions were as follows: 
94 DC for 3 minutes (1 cycle), 94 DC for 30 seconds, 43 DC for 30 seconds, 72 DC for 1 minute 
(5 cycles), 94 DC for 30 seconds, 55 DC for 30 seconds, 72 DC for 1 minute (5 cycles), 94 DC 











minutes (1 cycle). All PCRs were performed using a PE Biosystems GeneAmp PCR system 
9700 machine. 
2.2.3. Ligation of FoxGl N-terminal domain fragments into p-drive and transformation 
into E.coli 
Following amplification by PCR, the N-terminal domains were electrophoresed on a l.2% 
Agarose gel, viewed and excised under longwave UV light, and purified using the QIAquick 
Gel Extraction Kit (Qiagen). Purified DNA was ligated into the p-drive vector (Qiagen PCR 
cloning kit), according to the manufacturer's instructions (Fig. 2.3). The resulting p-drive 
constructs included the NFoxG 1 rat and human fragments with constructed BamH 1 and SadI 
cloning sites for cloning into the GR526 plasmid, and the NFoxG 1 rat and human fragments 
with constructed BamH1 sites on both 5' and 3' ends for cloning into the GFP plasmid. The 
ligation mix was transformed into E.coli DH-5a competent cells prepared by the method of 
Chung and Miller (1988). Transformed colonies were screened on Luria agar plates 
supplemented with 80 llg/ml X-Gal, 0.5 mM IPTG and 100 llg/ml Ampicillin, to screen for 
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2.2.4. Screening transformants for correct inserts 
Following transformation, white colonies were screened for the correct insert by colony PCR, 
using the same primers described previously (Table 2.2). 0.5 III of overnight liquid cultures 
were used as template in the following 20 III reaction mix: 1 X Supertherm Buffer, 2.25 mM 
MgClz, 0.25 mM dNTPs, 0.5 11M of each primer, 1.2 M betaine and 0.5 U Super-therm Taq 
DNA polymerase (Southern Cross Biotechnology). The cycling conditions were as follows: 
94°C for 3 minutes (1 cycle), 94°C for 30 seconds, 68°C for 30 seconds, 72°C for 1 minute 
(30 cycles) and 72 °c for 7 minutes (1 cycle). PCR products were visualized by 
electrophoresis on a 1.2% Agarose gel. Plasmid DNA from selected positive colonies was 
purified using the High Pure Plasmid Isolation Kit (Roche), according to the manufacturer's 
instructions, quantified with the N anoDrop ND-I000 Spectrophotometer, and sequenced 
using the forward and reverse primers (Table 2.2). Sequencing was performed by Gene Care 
(Cape Town, South Africa). 
2.2.5. Sub-cloning into pJasmids pGI_NMGR526 and p2J.lGFP 
For sub-cloning into pG I_NMGR526, the FoxG 1 N-terminal domain p-drive constructs were 
digested with restriction enzymes BamHI and SacII (Fig. 2.3). 50 III digests were performed 
using 0.1 U BamHI and 0.06 U SacII per 1 Ilg DNA, including 1 X Buffer Green (Fermentas) 
and incubated overnight at 37°C. Digested plasmid DNA was electrophoresed on a l.2% 
Agarose gel, and the NFoxG 1 domain fragments excised under longwave UV light. The 
excised fragment was purified using the QIAquick Gel Extraction Kit (Qiagen) according to 
the manufacturer's instructions. In order to remove the 761 bp yeast NM domain from the 
plasmid pG I_NMGR526, it was necessary to first perform a complete SacII digest, followed by 











enzyme was used per 1 Ilg DNA, with 1 X Buffer Blue (Fermentas), incubated overnight at 37 
0c. Following SaclI digestion, the plasmid was digested with 0.185 U per 1 Ilg DNA BamBI, 
with 1 X Buffer Blue. The reaction was incubated at 37°C, for 15 min, before the addition of 
1 X DNA tracking dye. 
For cloning into the p2IlGFP, the p-drive (BamHI-NFoxGI-BamHI) constructs were 
digested to completion with BamH 1, 50 III digests were performed using 0.1 U BamH 1 per 1 
Ilg DNA, with 1 X Buffer Green (Fermentas), and the digested inserts were purified as above. 
The p21lGFP plasmid DNA was digested with BamH 1 in a similar reaction mix. Digested 
plasmid DNA was electrophoresed and purified in the same manner as the digested N-
terminal domain inserts, and the 5' phosphates removed by Shrimp Alkaline Phosphatase 
(SAP), according to the manufacturer's instructions (Promega). Approximately equal 
concentrations of plasmid DNA and insert DNA were ligated in a 20 III reaction, including 
400 U T4 DNA Ligase (New England Biolabs) and 1 X Reaction Buffer. The ligation 
reactions were incubated at room temperature overnight and subsequently transformed into E. 
coli DH-5a competent cells. 
2.2.6. peR screening for correct constructs 
In order to screen for inserts in the putative recombinant pGI-BFIGR526 plasmids, colony 
PCRs were performed following transformation, using a GR526 specific reverse primer and the 
BF-I-BamHI forward primer (Table 2.2, Fig. 2.3). The reaction mix and the cycling 
parameters used were the same as those used for screening of inserts in the p-drive vector, 
with an annealing temperature of 55°C. PCR products were visualized on a 1.2% Agarose gel 











using both the BF-I-SacII and GR526 specific reverse primers, as well as the BF-l- BamH 1 
forward primer (Table 2.2). 
Similarly, E. coli colonies transformed with the ligation mix of the plasmid p2IlGFP, and the 
N-terminal domain inserts, were screened by PCR. A GFP specific reverse primer (Table 2.2), 
designed 24 bp from the start codon, and the BF-I-BamHI forward primer were used to 
check the orientation of the inserts in the plasmid, as only one restriction enzyme was used for 
cloning. The same reaction mix and cycling parameters were used, as for the pGI-BFIGR526 
screening, with an annealing temperature of 58°C. Following PCR, the products were 
visualized and the positive plasmids sequenced, using the GFP reverse, BF-l-BamH 1 reverse 
and BF-I-BamHI forward primers. 
2.2.7. Yeast transformation 
The following yeast strain was used for the assays: W303 (ala, ade2-1Iade2-1, trpl-lltrpl-l, 
leu2-31Ieu2-112, his3-11lhis3-15, ura3lura3, canrl-100ICAN). Yeast cells were transformed 
with either pGl-hBFIGR526 or pGl-rBFIGR526, and simultaneously with pL2/GZ by 
electrophoration (Table 2.1, Ausubel et al., 2001). Yeast were also transformed with pGl-
NMGR526 and pL2/GZ, as a positive prion control, and pG I_GR526 with pL2/GZ, as a 
negative prion control (Table 2.1 and 2.3). p2)lGFP, p2)l-hBFIGFP, and p21l-rBFIGFP were 
all separately transformed into yeast cells. Following transformation, all yeast transformed 
with the GR526 based plasmids and pL2/GZ were plated on leucine and tryptophan deficient 
media, while GFP based plasmids were plated on uracil deficient media (Table 2.3) To 
confirm transformation, yeast cells were recovered from a stationary phase culture and were 











with 0.02 ml 2.5 mg/ml Zymolase solution (Sigma), to digest the cell wall. Following 
treatment the cells were recovered and plasmid DNA was purified using the High Pure 
Plasmid Isolation Kit, according to the manufacturer's instructions (Roche). 
Table 2.3. Individual transformation of plasmids into yeast, selective media used, and purpose of 
transformation (control or experimental). 
Plasmids transformed Selective media Control or experimental 
pG l-hBFI GR526 and pL2/GZ -leu -trp Human N-terminal experimental 
pGI-rBFIGR526 and pL2/GZ -leu -trp Rat N-terminal experimental 
pGI_NMGR526 and pL2/GZ -leu -trp Positive prion control 
pG I_GR526 and pL2/GZ -leu -trp Negative prion control 
p2Jl-hBFI GFP -ura Human N-terminal experimental 
p2Jl-rBFIGFP -ura Rat N-terminal experimental 
p2JlGFP -ura Negative prion control 
2.2.8. Growth on X-gal media and p-galactosidase assay 
For the ~-galactosidase assay, yeast transformed with GR526 based plasmids and pL2/GZ were 
inoculated in 5 mls of -leu -trp dropout media, and grown to early stationary phase at 30°C 
(OD600nm = 1). Following growth in liquid media, approximately 300-600 cells were plated on 
dropout media agar plates and incubated for 4 days, or until colonies appeared. Colonies were 
velvet replica plated onto X-gal dropout media agar plates containing: 1 X BU salts (0.2611M 
Na2HP04:7H20 and 0.25M NaH2P04) and 80 mglL of X-gal. Replica plates were grown for 4 
days at 30°C, or until colonies appeared. Blue and white colonies were counted. Blue and 
white colonies were picked and individually grown in 5 ml cultures to stationary phase, 











percentage of blue colonies converting to white, and the percentage of white colonies 
reverting back to blue, was assayed. Three individual transformants, from each 
transformation, were plated in triplicate. 
2.2.9. Fluorescent microscopy 
Yeast cells transformed with the GFP constructs were viewed using fluorescent microscopy. 
Cells were grown in -ura dropout media to early stationary phase (OD600nm = 0.8) at 30°C. 20 
f..ll of the cultures were viewed on glass slides (B&C, Germany) under the light microscope, 
using the (FITC) filter to measure GFP fluorescence. The Nikon Eclipse E600 fluorescent 
microscope fitted with a 100 X objective lens was used, and the images were captured with a 
Media Cybernetics CooISNAP-Pro monochrome cooled CCD camera. 
2.3. Results 
2.3.1. The N-terminal domains of FoxGl have no predicted secondary structure 
The N-terminal domains of prion proteins are often rich in polar amino acid residues, amino 
acids repeats, and are devoid of predictable secondary structure (Lindquist, 1997). The amino 
acid sequences of the human, rat and Xenopus FoxG 1 orthologues were analysed using the 
IUPred server, to determine whether the HlP/Q rich N-terminal domains show conformational 
flexibility. The application estimates the pairwise energy content of amino acid sequences, 
based on the likely interactions between the residues, and is able to distinguish between 
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Figure 2A. Disor.J.>r le .. tle •• J or the ~mino arid •• sidu"" of Ih. human (A), rat (S) "!HI Xenupus (e) 
Fu~Cl ""rhologues Vab., abo,c 0,5 show hi~h 100eb of d;,.--.-d<,. and as a .. ,ul< prodi,-tion ~f ,.,-~nd",)' 
, In>elll'" "lH IIN,,,ible, V.lul" bdu" 0.5 !'C1~l"enl Ii",,,, 'e,iJ,~·, pre,en! in don .. ;", for which structun' aJld 
u"Tln,ic foll1in~ can 1><' rttd ldcu. Ill,' t>,'-lc,',,,inal un<lL,in, uf til<' onllOl"gue' SilO" ,onformal ion"1 fleXl!>I IJl)' 
(i 1_ "htle LC': e(l","n"d I)'M ~mJli'g (Ii ) a,>l C -lmIll ,,,,I (iii) U"iilai,C' u"pl ay ",,,in'I<' f()lding 1~'{>I><·j[ic.. 'Ik 
amln(l ocid "''111''"("0 (If I he 'l_lormm,,1 d(lfllain ~ I te..· hLlm:m F~,(; I pr(ltein i, ,ho,,,'.-n I-clm, i D). ",ilh the HII'IQ 
'ich region highli~ht"d, and Ih("" ,,,,!d l,,,, urU..I'''' t~ the human "'Gu,,,,,," (compareu ", LOC raL) Lu>ler lincd. 
TI", N-lerr\li ll~1 d()r\lJlll' () f the ()Tlh()l()gue, (re, idu~, I t() approxlnlaldy 164 in human. I to 
155 ill ral and I to I]() ill Xenopus} di'played hlgh level, of <:()nfOrrllJIi()nai fle~ ihil ily (Fig. 
2.4), The hunWIl ortl)(llogu~. in mmpari,on 10 the ral and Xenopus, soo .... ed a silghtl)' ili)!her 
su,tained I~"el of tlexihiWy in Ihe !\-termill,d domaill, "jlh ,1 larger region of ~rnino ~"id, 











maIko '1 he rJl Jnd Xenopus ;-.JFo.~Gl domain, rea<:hellthi: rna"imLim k,cl of 1.0. but showed 
dip> in the di'older tendency of lhi: amino a,'id r~,illu~.1 atlc.liduc 110 and residues 60 to 85. 
r~,pe,·ti~~ly. Th~s~ uips in di.lordcr tendCllcy can be correlated with th ~ differcn,'el in lhi: 
.ICq"CII<YI; toc d,p Ihown by thc rat sequence corre'pond, 1.0 th~ po.llllUn of thc six prolinc 
IC.liduc, lacking in the se~ueoce . but pr~""nt rn Ih~ h"man NFo~GI domain (hg. 1.2 Jnd Fig. 
2.4. DJ. The di p in the lI isorder l ~mkncy of the Xnw{'".\· ~FoxGl domain occurs at the 
position of lh~ poly (QI and poly (P) lIacts lacking in the >equen<.:e, bUI pr~>ent in lht:e 
mammal,an onhologues. Sccondary >tru,-Iur~ i> ~as il y predicled ln thc consC["vcd D~A 
binding and cJrbo.\y-tnminal domains. adjaccnt to thc l\-lcrminal. The N-tenninJl dOIHainl 
of Fox G 1 ()flhologu~, a[\: toc [dorc i III rinsicJJJ y ,mfolded region>. whkh in<.: I "d~ H/P/Q nC h 
rcglOn, and many G/A amino acid residue'. 
2.3.2. Cloning or Ihe N- terminal d omains in to the giu("Ocor til-uid receptor plu~mid , pG \ -
Nl\ IG R510 
Th<e ,",-t~rminal uomain, of rat and human l'oxGl we[e fus ed to J constitutively active rat 
ghlCoconicoid receptor (GK\l1i). to i nv~stigal~ whelhi:r thi: domain can inducc a 
,'onfonnalionul swil<:h in anOlhi:r protein. TI1C N-tcrminul domains of rat (492 bp) and human 
1.~19 bpj FnxGl wc[\: amplilicd by pt'R "'ith FoxGI specific plirrl<:r> (Fig. 2.51 Th~ prin""r\ 
wcre designed to com.tnICt tlamHl amI S~dI r~'tri,·tion enl.ymc .liIC'. on thc 5" and 3' cnds 
respectively. to ~nable doning into toc plJsmid pGl-~~IGR"'. The PCR ftagments \' ere 
initially cloned into the p-driw v~dm, ~nd suh-cloncd mto toc pG I-NMGR'" plasmid. 
In older to sub-clone the Fo.\Gl "-lnmin~l domain fmgmcnl_1 into pGl-Nr.IGR'''. the l\M 











determinant. wa, removcd via digestion with SadJ and p~r1"11 dige.'l ion with flamHI and 
replaced with the 1'0xG I N lenninal fJ:tgmcms digcsted out Oi'lhe p-dTi"e vedUT. A cunlplele 
]janllli digest uf the pUI - l\"'IGR'~" vector WaS riot pmsihk due 10 a second RarnH I 
re~uglliliull >il~ on tbe 3' end uf the GR':" in<en (rig, 2.3). A UR 'C" specific reverse primer 
Wa, used to con firm t he suh-~ lUlling uf th~ N -t~rmjn'll doma; 0, illl" th,- partially Jig:e ' ieJ pU 1-
l\ MUR '~" , 11'e re.\.U lli ng conslructs were screened h)' peR, I-'.il h t.he Fo~G I 'pe<:itic fum ard 
primer .lIld a GR'"" >pccifk re\'enc primer (Table 2.2, ['ig. 2.3). The ['oxG I and GR~!" 
Figuh' 2.5. peR amplificaliun ur lhe ral "nd h"man F o~c, I N_lecminal d"main" )'0'(; I 'p.,: i Ilc pri "''''' 
wcr. ""'d. "ILLch were Jc"£"ed Lo e""hk 'he addui,," 01' BamHI aoo S.1clI re_tri<;,ion "",ym" ,i'"' Of] (he 5" 
,,00 " "",I, ""p<ct i,'dy, MM ; [)I<.'I,,'ui:or "'e igh' """keT (~D"'AlPstI), applicwle frogment , i,e, (Kb) are 
, I"w" along,ide. - ,'e. neg,Wi,-e PCR .'n_nn-ol, in"l u<iing PCR ~".Je wm."-.,, the (e"')llme. H' hLJm.1n N_termillol 
J"m.1in . 5 1<1 tp. R: rat N_LeTminal Jom"in. 492 hp 
specific pri m~p, 0111)' produ<:cd a peR prod UC I \\'h~ n the d~>i red wllslruc1 W'IS present 'IS a 











foxG I were fused directly to GK'!" (Fig. 2.6). rhe PCI{ <;<;reening ~lIowed e~<:Iu,i()n o ( 
constructs which (!id nol produ<:e peR produci. and Iherefore (lid not con tain tbe foxG I :-,r. 
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rig""." 2.6. PCR ><H','uiug of h"m"u "nd !'at :"H~"",inal (;R'" e(ln,tmet,. h,,(J I · llamH 1 'l)tcLi'", [utwor" 
and GR'" 'pcull" 'cycr-c pm'"'''' "en' useJ 10 s<:" .. " o",,,truel, fo r pO I·h RF I (o l{"" (A I, "nd p(; 1 TilE-' 1 GR'';:' 
(R). M\t ITK,ICCLllar wcighl lIl", ~ er O.l)"AlP,Il ). applicable fragme nt ,ize< (Kbl ;,re ,t.,"',n al()n~."dc ,e: 
neg,tiw PCR cont r()! . il>dLKll l>g PCI{ ~".adc "'",ilCT"' Illc template. (A) ~amplc, 1. .1 "'xl 4 ,hOI' rc-",i li\'c PCI{ 
predllc!>. oltd thu, the de'ired humo" F",(JI " ·"'Tminal (JI/.'''' "Onslmd. (II) Sampb.1. 4 oOld 6 ,how )~"it i\'e 
PCR prC)(itlCt', the '''' ired '01 F",O I r\ ·'erm i nal GR"& "OnSlrocl. Sample 2 (Al an" ;;.a,,~),", I, 2 ond 5 I R I ,1>.",' 
,~, PCR l)roJLKt, "xl Ih.,.f~r., "', root ind lldc the F",O I N·'crmi nu, aoo (;1/.' ''' iLl [I" ""(fed "<ient,I],,,' . The 
(JI{'" 'l"'cifL" Te,e"'" prim,," ""a, (b ig,,,,d 222 bp (i<1wn'lreolTI ol"he 'toTt ""&)0 Lhll' ,he hll lllan PCR 1"00"<:1 
i< 7'8 br in ,i/e and ,he T., 71 I hp 
2.3.3. P-gllillciosidllsc ~"a~' in ~'ca~1 - the Fox(;1 '.-terminal domain~ lire able to l'Onr~r 
upon GR"~ a chan~e in confonnation 
Foliowing l'bsmid con-;truction and v~rifica!ion via scq u~n~ing (,ee 'upp l e ll ~ nl ary dala. Fig. 
S I and fig. S2). lh~ rat and hum:m .:'H·,,~ Gl :GRs2, con ~ t ruc t , wCrC Iransfon nl'{] into wildtypc 
ye~' 1 c~ l b, " ,tb lhc GR,eG rcgulalnl fl-galactosidase plasmid pL21GZ 10 ,~r~(n ,,·hctber they 













indu<:~d <:< lflformiltio"al , .. hangc (Fig, 2.2). TIIC tr~n'fnm""d }Ca-i colonie, "ere n::plica plalcd 
onlO X-gal meliia, I"o llowing growlh on -Icu -lrp dropout nledLa, 10 determine Ih~ colour 01" 
IOC colonics, 
Figm< 2.7, ,\n"I)',;" of {'(~ODy «~our "hen pla .. d on X.gal media (A 0 Colon"" pmJuccu "hen 1,,,1 plJlcu 
on X gal rr .. :(lia, mO CLliLK,,,,, pnMloced foltLlwing replaLmg ol\d\>le col"n." on X-gal mcdu. (i) pG I·(;R' '''. til(: 
GR' ''' """,,,,I C',,",Lru,", pr(Ml""od ~I u. yoa,' "n lom., and 0"" white "()~,"y. v.hic'h uI~'" ",plating ne' or re"erL«1 
bad. to N ut, 1 ii i pC. 1_"I\lGR 'C. the 1""lIi,'o PC"'" CO""ol. l"oJuc.d " 'hOle cok'"ie', which "'"'' "ble to '.'ert 
hac, '" blut uI~'" '-el'I"lin ~ 1'>1"""'). (ii i) p('oI_hBF I GR< ~', ,he humon "O",truc", produc .. I l-< "h hi"" ,HId "hi,. 
colonio" which ,.wned ~;x-k 1" blue (",mw,) Human m,,,OIC colon) ,ho"'n a" Ill'ert, Bo(h the p'-'TConw~. of 
c.iI, com'o rting fm", oil., 10 "hote. ,"\{I "'l1i1< 10 t>!1JC _ "'" "".: 11 higher than IllOSe of tile "" con",,",1 , ( i\ I pC 1-
rBFIGR"', [he ralc'"""U,,cI, l",oJLlCed blue aoo "hM colonLf' ,oJ "I,laUng ,,1111<' colon,", ,",,,lieu in" >mal l 
rercen",~e of Ihelll f",'eJ ling k lC llo blue (.w-,o,"!. 
prod\H,:ed blue colonies and only one whitc colony (O.OYii). This colony did nUl revert bacl to 
blue upon n::plating Wig. 2.7, L and 2.R). Tile cell" Iralh l"Onlled wilh pG I_I\MGR~'G prodlLC~d 
blue colonic.,. and while colonies (0,74%). U,OJ'}( of white colonies reverted back to bluc, 
"hen r~plaled (Fig, 2.7, ii. Fig, 2.R). The human ~on'trud pr()duccd the nlml intriguing 
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flumc",~"' miCT(l"'OI'Y 101"£"' aTC cii,pl.yed .hove tbe lighl m i..: ",,,-,opy nllJgc, ()f 'he ,"me cdb. Yc", ' 
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plasmid p2~,Gf'P cnntaill<'d so luhle GFP (Fig. 2.12). The experimental plasmid< on the other 
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,uch a, Sup35 :-J!\1 domain (Palino er <II" 1\.1% , Si er al. 20(3). AggITgates of similar ~Ize, 











fluorescence was visible within the cells displaying aggregates; however the intensity of the 
fluorescence differed, from bright to relatively faint. 
2.4. Discussion 
Possible prion-like properties of the rat and human FoxG 1 N-terminal domains were 
investigated, using two assays originally designed for yeast prions, and subsequently used to 
investigate the Ap/ysia CPEB protein (Li and Lindquist, 2000, Patino et ai., 1996, Si et al., 
2003). The N-terminal FoxG 1 domains were of particular interest due to the unusual amino 
acid composition, including poly (H), poly (Q) and poly (P) tracts, which differed between the 
rat and human FoxG 1 orthologues, as well as many glycine and alanine amino acid residues. 
Prion proteins frequently contain tracts of single amino acid residues, for example poly (Q) 
and poly (N), in their N-terminal sequences, as well as oligopepetide repeat sequences 
(Shorter and Lindquist, 2005 and Si et aI, 2003). The rat and human orthologues were chosen 
for this study to investigate whether the differences in composition of their N-termini, namely 
the insertion of poly (P) tracts seen in the human sequence and absent in the rat, correlates 
with the differences in their prion-like properties. 
In comparison to the remainder of the proteins, the N-terminal domains of prions often 
display high levels of conformational flexibility (Derkatch et ai., 2004, Shorter and Lindquist, 
2005). The NFoxG 1 domains of FoxG 1 orthologues (human, rat and Xenopus) were found to 
be intrinsically unfolded protein sequences (Fig. 2.4). When compared to the DNA binding 
and C-terminal domains, conserved regions of the orthologues capable of folding into 
predictable secondary structures, the NFoxG 1 domains showed high conformational 











flexibility, the amino acid sequence showed a sustained disorder tendency greater than 0.9, 
with a large domain of amino acids showing a maximum disorder tendency of 1.0. However, 
while reaching the maximum disorder tendency of 1.0, the rat and Xenopus NFoxG 1 domains 
showed increasingly lower levels of disorder, with an even greater number of residues in the 
Xenopus sequence reaching only the 0.9 mark. A brief dip in the disorder tendency in the rat 
sequence and an expanded one in the Xenopus sequence corresponded to the differences in the 
sequences when compared to the human NFoxG 1 domain. The position of the dips 
corresponded to those amino acids absent in the rat and Xenopus sequences consisting of poly 
(P) and poly (P/Q) tract insertions in the human sequence, respectively (Fig. 1.2, 2.4). These 
results show that the greater the number of proline and glutamine amino acid residues in the 
poly (P/Q) tracts, the greater the conformational flexibility of the NFoxG 1 region, as seen in 
the brief dip in the rat sequence, when lacking six proline residues, and the larger dip in the 
Xenopus, when lacking a 27 residue tract present in the human sequence. This initial result 
provided further motivation to investigate possible prion-like properties of the N-terminal 
domains of FoxG 1 orthologues and compare the possible differences between them, 
corresponding with the differences in their amino acid sequences. 
Prion-like properties of the N-terminal domains of FoxG 1 orthologues were investigated by 
fusing these domains to a constitutively active rat glucocorticoid receptor. The assay was used 
to determine whether the N-terminal domains are able to confer upon another protein a 
change in conformation. The rat NFoxG l:GR526 constructs behaved in a similar manner to the 
prion control plasmid, consisting of the N-terminal domain (NM) of the yeast prion 
determinant Sup35. Although the GR526 protein was in the active conformation in the 











constructs showed a switch to an inactive GR526 conformation (Fig. 2.7, 2.8). Upon replating, 
the inactive conformation was seen to be inherited by daughter cells, but on occasion would 
revert back to the active state. The human NFoxG l:GR526 construct had different properties: 
the GR526 protein present in the yeast transformed with the human construct was also able to 
exist in both the active soluble state, as well as the inactive, aggregated state. However, the 
percentage of conversion between the two states was higher, in comparison to the rat and NM 
constructs. The presence of blue and white mosaic colonies implied that the percentage of 
cells converting was so high, that even in single colonies, the cells contained both active and 
inactive GR526 conformations. Cells transformed with the GR526 construct produced only one 
white colony, which did not revert to the active conformation. It is suggested that this white 
colony was a result of a spontaneous mutation in the GR526 protein, rather than spontaneous 
amyloid formation. 
The N-terminal domains of rat and human FoxG 1 orthologues were able to form aggregates 
in vivo. Cloning the NFoxG 1 regions into a GFP plasmid allowed the visualization of these 
aggregates using fluorescent microscopy. GFP was soluble in vivo and was not seen to 
aggregate within the cells (Fig. 2.12). The rat and human FoxG 1 N-termina1 domains, were 
however able to induce aggregation of the GFP within the yeast (Fig. 2.13, 2.14). Both large 
and small aggregates were visible, as well as soluble protein. The presence of GFP aggregates 
of similar sizes in recently divided cell groups, and in budding daughter cells confirmed the 
heritability observed in the p-galactosidase assay. The percentage of yeast cells containing 
aggregated GFP was similar for the rat and human NFoxG 1 constructs, although no actual 
quantification was performed. In a number of the cells containing aggregated GFP, the 











investigated the formation of prion fibres by the Sup35 prion determinant and suggested that 
prior to prion fibre formation, protein conformation is lost and the protein is temporally 
present in a molten, unstructured form. It is suggested that these lower levels may also be a 
result of the accumulation of similarly unstructured or molten GFP, which was present in 
anticipation of adding to the already present aggregates, as the fluorescence of GFP depends 
on properly formed tertiary structure (Patino et al., 1996). Alternatively, the lower levels of 
background soluble GFP, seen in cells with aggregated GFP, could be a result of the depletion 
of soluble protein due to aggregate formation. 
Thus, the human and rat orthologues of FoxG 1 share a number of traits with known prions: 
their N-terminal domains are unstructured, and contain tracts of amino acid residues, namely 
proline, glutamine and histidine, and the domains are able to confer a conformational change 
in other proteins, which is heritable. The human and rat NFoxG 1 domains were also able to 
form aggregates in vivo. As previously discussed, not all proteins which are able to exist in 
distinct conformational states are prions: prions are proteins capable of infectious fibre 
formation (Shorter and Lindquist, 2005). Although the aggregates present in yeast cells in this 
chapter were seen to be heritable, the results are preliminary and do not confirm infectivity. 
In the next chapter, the physical properties of the conformational change in the GR526 protein 












Characterization of the prion-like properties of the N-terminal of FoxGl 
3.1. Introduction 
In the previous chapter, it was shown that the N-terminal domains of the rat and human 
FoxG 1 transcription factors were able to confer upon the glucocorticoid receptor protein a 
change in conformation. In the ~-galactosidase assay, the NFoxG 1 domains were able to alter 
the conformation of the GR526 protein, rendering it inactive and resulting in white yeast 
colonies. It was hypothesized that the white colonies seen in the assay were a result of one of 
three distinct mechanisms, namely a reduction in GR526 expression levels, a mutation in the 
GR526 protein, or amyloid formation, whether prion or non-prion amyloid based. In this 
chapter, these possibilities were investigated using several diagnostic tests for prion proteins. 
Western blot analysis was performed in order to determine whether the GR526 protein was 
expressed at similar levels in the blue and white colonies seen in the ~-galactosidase assay. 
Previous research on the Aplysia CPEB protein has shown that the protein is able to alter the 
conformation of the GR526 protein in the ~-galactosidase assay, resulting in white yeast 
colonies in which the GR526 protein is expressed at similar levels, when compared to protein 
extracted from blue colonies (Si et al., 2003). 
Subsequent investigation into whether the white yeast colonies seen in the ~-galactosidase 
assay were due to a mutation in the GR526 protein was performed by growth on guanidinium 











which has been shown to cure prion fibre formation (for example ApCPEB, Sup35 NM 
domain and [URE3]) when present in low concentrations, while proteins in which a mutation 
has occurred are not cured (Chernoff et al., 2002, Li and Lindquist, 2000, Si et al., 2003, 
Wickner, 1994). The ability of GuHCI to cure a conformational change suggests a possible 
infectious prion-based mechanism, opposed to a non-prion amyloid mechanism (Chernoff et 
at., 2002). Curing by GuHCI is not caused by denaturation of the prion proteins; as such low 
concentrations are used. Rather, curing results from the repression of prion fibre proliferation 
in dividing cells. Thus, several generations of growth on GuHCI are required to cure a prion 
state, as the preexisting prion aggregates are diluted sufficiently amongst progeny, but are 
unable to self propagate. In this study, white colonies transformed with the human and rat 
NFoxG 1 :GR526 constructs were grown on GuHCI supplemented media and the colour of the 
progeny determined. 
Thirdly, evidence that the inactive state of the GR526 protein was a result of aggregate 
formation was obtained by examining the sedimentation rates of the protein when extracted 
from blue and white colonies. Previous studies have shown that the aggregated state of a 
prion protein sediments at a different rate than the soluble protein, being detectable in lower 
fractions on a sucrose gradient (Chernoff et al., 2002, Si et al., 2003). For example, the 
soluble state of the Aplysia CPEB protein was detected in fractions five and six, when an 
ultracentrifuged sucrose gradient was fractionated and numbered from the top downwards. 
The amyloid state of the protein was however detected in fractions nine and ten (Si et aI., 
2003). Thus, the sedimentation rates of the GR526 proteins in white and blue colonies were 
investigated in this study, providing further evidence to support the presence of the aggregates 











In the event that the inactive state of the GR526 protein was found to result from an alternative 
conformation, the mechanism of aggregate formation would be determined, whether prion or 
non-prion based. As previously discussed, pnons are proteins capable of infectious, self-
perpetuating amyloid formation (Prusiner, 1998). However, amyloid forming proteins do 
occur naturally, which are not infectious and are not considered prions (Shorter and Lindquist, 
2005). For example, Alzheimer disease results from amyloid formation in brain tissue, 
resulting from poly-glutamine tract insertion in the ~-amyloid precursor protein (~APP), but 
the disease is not infectious (Checler and Vincent, 2002). Yeast mating experiments can be 
used to establish whether a suspected prion-like conformational change in vivo is 
transmissible (or infectious ). Yeast cells can either be diploid or haploid, with haploid cells 
being either of two mating types, namely alpha (a) and a-types. An assay has been developed, 
in which blue and white a and a-type cells from the ~-galactosidase assay are mated. If the 
inactive prion-like state of the protein is infectious, the progeny will be white in colour 
(Chernoff et ai., 2002). This assay has been used successfully to demonstrate the infectivity 
of the Aplysia CPEB protein (Si et al., 2003) and the Sup35 NM domain (Li and Lindquist, 
2000). 
In order to perform the yeast mating experiment, the rat and human NFoxG 1 :GR526 domains 
were sub-cloned into the p YES2 yeast vector and transformed into the a-type yeast. The 
original plasmid constructs used in the ~-galactosidase assay were transformed into an a-
mating type yeast strain. In order to establish whether the change in conformation was 
transmissible to uninfected cells, white yeast colonies, containing the inactive GR526 
conformation, were mated to blue colonies and the colour of the progeny determined (Fig. 
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3.2. Materials and methods 
3.2.1. Total protein extraction from yeast 
Total cellular proteins were extracted from blue and white yeast cells transformed with either 
pGl-hBFlGR526 or pGl-rBFlGR526, blue cells transformed with pGI_GR526, used as a 
control for the active conformation, as well as untransformed wildtype cells, used as a 
negative control. Cells were harvested from overnight 50 ml YPD cell cultures, inoculated 
with either a blue or white colony (OD600nm = 0.4-0.6), by centrifugation for 5 min, at 3000 
rpm at 4 DC. Cells were washed once in ice cold sterile 1 X PBS, and harvested once again. 
Cell pellets were frozen in liquid nitrogen, and stored at -80 DC until proteins were extracted. 
Total cellular protein was extracted using the TCA method described in the Clonetech Yeast 
Protocols Handbook (2001), with the exception of the composition of the TCA buffer (20 mM 
tris-HCI pH8, 50 mM ammonium acetate, 2 mM EDTA). Protein concentrations were 
determined using the Bio-rad protein assay kit II (Bio-rad), according to manufacturer's 
instructions. The following standard concentrations of BSA were used as reference samples: 
5, 10, 20, 30, 40 and 60 Ilg/ml. 
3.2.2. Western blot analysis 
Prior to SDS-PAGE, samples were boiled for 3 minutes in 1 X sample application buffer. 20 
/lg of each sample was electrophoresed on a 5% acrylamide stacking gel, and a 12% 
acrylamide separating gel, at 95 V. SDS-PAGE low range standards were used as molecular 
weight size markers (Bio-rad). Following electrophoresis, proteins were transferred in a tank 
transfer system overnight to a protran nitrocellulose transfer membrane (Schleicher & Schuell 
Bioscience), at 30 V. Membranes were subsequently stained with Ponce au S (Sigma), to 











X TBS, overnight at 4 0c. The membranes were incubated with primary antibodies in 2.5% 
skim milk in 1 X TBS, for four hours (Ausubel et al., 2001). One membrane was hybridized 
with 0.5 /lg/ml Rabbit polyclonal GR specific antibody (Abcam, ab3579), while the other was 
hybridized with 0.5 ~lg/ml Rabbit polyclonal GAPDH specific HRP conjugated antihody, 
used as a control (Abcam, ab9385). Following incubation with the primary antibodies, the 
membranes were washed in 1 X Wash Solution, provided with the LumiGLO Reserve 
Chemiluminescent Substrate Kit, according to the manufacturer's instructions (KPL). The 
membrane incubated with the GR specific primary antibody was subsequently incubated for 
one hour with 0.05 /lg/ml goat anti-rabbit IgG secondary antibody (KPL), in 2.5% skim milk 
in 1 X TBS. All of the membranes were washed in 1 X Wash Solution, and exposed to the 
luminol-based chemiluminescent substrate, using the LumiGLO Reserve Chemiluminescent 
Substrate Kit, according to the manufacturer's instructions (KPL). Following exposure to the 
substrate, the membranes were exposed to Super RX medical X-ray film (Fuji) for 3-30 
seconds, placed in developer (AGFA) for 1-2 minutes, rinsed in water and placed in rapid 
fixer (AGF A) for 2 minutes. 
3.2.3. Growth of yeast on GuHCl supplemented media 
White yeast cells transformed with either pGl-hBFIGR526, pGl-rBFIGR526, pGI-NMGR526 
or pGI_GR526 and simultaneously with the pL2/GZ construct were grown on YPD media 
supplemented with 5 mM guanidinium-hydrochloride (GuHCl). Small amounts of overnight 
liquid cultures, inoculated with white yeast cells, were patched onto YPD GuHCI agar plates 
and incubated at 30°C until the patch of colonies appeared. Following growth, the colonies 
were velvet replica plated onto fresh YPD GuHCI agar plates. This process was repeated three 











al., 2002). Following growth on the YPD GuHCl agar plates, individual colonies were 
streaked out on YPD GuHCl agar, and subsequently patched onto solid X-gal supplemented 
dropout media to determine the state of the GR526 protein within the cells. Three individual 
transformants for each of the GR526 based constructs were assayed in triplicate. 
3.2.4. Preparation of total celllysates 
Overnight YPD cultures were inoculated with yeast from either blue or white colonies 
transformed with the plasmids outlined in Table 3.1. Total celllysates were prepared from the 
100 ml cultures of the yeast, using the method outlined in Si et al. (2003). Cells were 
harvested by centrifugation at 3000 rpm, for 5 minutes at 4 DC. The yeast cells were washed 
once in 1 X PBS, and resuspended in 500 III lysis buffer (Si et al., 2003). Cells were broken 
with 500 III glass beads (Sigma), by vortexing for 10 min at 4 DC. Samples were centrifuged 
for 20 minutes, 13 000 rpm at 4 DC, to eliminate cell debris. Protein concentration was 
determined as previously described (Chapter 3.2.1). 
Table 3.1. Cell lysate preparations were collected from various transformed yeast cells. 
Cell lysate preparations 
Blue pGl-hBFlGR526 & pL2/GZ 
White pG l-hBFI GR526 & pL2/GZ 
Blue pGI-rBFIGR526 & pL2/GZ 
White pG l-rBFlGR526 & pL2/GZ 
Blue pGI-NMGR526 & pL2/GZ 
White pGI-NMGR526 & pL2/GZ 
Blue pG I_GR526 & pL2/GZ 
Control or experimental 
Human N-terminal experimental 
Human N-terminal experimental 
Rat N-terminal experimental 
Rat N-terminal experimental 
Positive prion control 












3.2.5. Sedimentation of proteins on sucrose gradients 
Following preparation of cell lysates, approximately 1 mg of protein from each sample was 
loaded onto a 2 ml sucrose gradient. The sucrose gradients consisted of 1.5 ml 30% 
(weight/volume) sucrose in lysis buffer, layered above 0.5 ml 40% sucrose in lysis buffer (Si 
et ai., 2003). The sucrose gradients were centrifuged using the Beckman SW65i rotor for 1.5 
hours, at a speed of 40 000 rpm at 4 0c. Following centrifugation, 200 III fractions were 
collected from the top of the gradients, numbered from one to ten from the top downwards, 
and stored at -80°C prior to western blot analysis. 
3.2.6. Western blot analysis of sucrose gradient fractions 
Following collection of the sucrose gradient fractions, 20 III of the fractions numbered two to 
ten were electrophoresed via SDS-PAGE, as previously described. Each of the sucrose 
gradients (fractions two to ten) was electrophoresed on a separate 10% acrylamide gel. 
Western blots were performed as described in 3.2.2, with incubation of all of the membranes 
with the GR specific primary antibody. Detection of the GR526 protein was performed; the 
membranes were subsequently stripped (Ausubel et ai., 2001) and the western blots repeated 
with the GAPDH specific antibody. 
3.2.7. p YES2 based plasmid construction and screening, for yeast mating experiments 
In order to sub-clone the rat and human NFoxG 1 :GR526 and the NM:GR526 domain into the 
pYES2 vector (Invitrogen), the pYES2 plasmid, pG1-NMGR526, pG1-rBF1GR'i26 and pG1-
hBF1GR526 were digested overnight at 37°C, with the restriction enzyme BamHl. 50 III 
digests were performed using 0.1 U BamH1 per 1 Ilg DNA, including 1 X Buffer Green 











fragments excised under longwave UV light. The excised fragments were purified using the 
QIAquick Gel Extraction Kit (Qiagen) according to the manufacturer's instructions. 
Approximately ISO ng insert DNA and SO ng plasmid DNA were ligated in a 20 III reaction, 
including 400 U T4 DNA Ligase (New England Biolabs) and 1 X Reaction Buffer. The 
ligation reactions were incubated at room temperature overnight and subsequently 
transformed into E. coli DH-Sa competent cells (Chung and Miller, 1988). Following 
transformation, colonies were screened by PCR, to determine the orientation of the inserts 
within the p YES2 vector. O.S III of overnight liquid cultures were used as template. The 
reaction mix and cycling parameters are the same as those described in 2.2.4, with an 
annealing temperature of SO dc. A GR526 specific reverse primer was used (Table 2.1); with a 
T7 specific forward primer with the following sequence: S' TAA TAC GAC TCA CTA TAG 
GG 3', Tm 46°C. PCR products were visualized by electrophoresis on a 1.2% Agarose gel. 
Plasmid DNA from selected positive colonies was purified using the High Pure Plasmid 
Isolation Kit (Roche), according to the manufacturer's instructions and sequenced using the 
forward and reverse primers used for PCR screening. 
3.2.8. Yeast transformation 
The following yeast strains were used for this study: W303-1B (a, leu2-3, leu2-I12, trpI-I, 
ura3-I, his3-11, his3-I5, ade2-I, canI-IOO) and W303-1B/A (a, ade2-I, ura3-I, his3-11, 
his3-I5, leu2-3, leu2-112, trpI-I, canI-IOO). Following sequencing and selection of plasm ids, 
yeast cells were transformed with the plasmid constructs by electrophoration (Ausubel et ai., 
2001). The a-mating type strain W303-1B/A was transformed with either pYES2-hBFIGR526, 
pYES2-rBFIGR526, or pYES2-NMGR526 and simultaneously with pL2/GZ, and cultured on 











5~6 5'6 5'6· . pGl-hBFlGK- ,pGl-rBFlGK- , or pGI-NMGR - and sImultaneously with pL2/GZ, and 
cultured on selective media. 
Table 3.2. Individual transformation of plasmids into yeast, selective media used, purpose of 
transformation (control or experimental), and yeast mating type. 
Plasmids transformed Selective media ala Control or experimental 
pG I-hBFl GR526 and pL2/GZ -leu -trp a Human N-terrninal experimental 
pGl-rBFlGR526 and pL2/GZ -leu -trp a Rat N-terrninal experimental 
pGI-NMGR526 and pL2/GZ -leu -trp a Positive prion control 
pYES2-hBFIGR526 and pL2/GZ -leu -ura a Human N-terminal experimental 
pYES2-rBFIGR526 and pL2/GZ -leu -ura a Rat N-terminal experimental 
pYES2-NMGR526 and pL2/GZ -leu -ura a Positive prion control 
3.2.9. Growth on X-gal media and p-galactosidase assay 
To determine whether the GR526 protein within the yeast cells was in the active or inactive 
state, transformed yeast cells were inoculated in 5 mls of -leu -trp or -leu -ura dropout 
media, supplemented with galactose to activate the p YES2 GALl promoter (Table 3.2), and 
grown to early stationary phase at 30°C (OD600nm = 1). Following growth in liquid media, 
approximately 300-500 cells were plated on dropout media agar plates and incubated for 4 
days. Colonies were velvet replica plated onto X-gal dropout media agar plates (as described 
in 2.2.8). Replica plates were grown for 4 days at 30°C, or until colonies appeared. 
3.2.10. Yeast mating 
Following identification of blue and white colonies from each transformation, the 











· )')6 5')6 
Blue a-type cells transformed wIth the rat and human NFoxG 1 :GK - and NM:GR -
constructs were mated to white a-type cells transformed with the p YES2 based rat, human and 
NM constructs, respectively. White a type cells were similarly mated with blue a-type cells. 
All matings were performed in triplicate. Following growth overnight on YPD, yeast cells 
were cultured on triple dropout, -leu -trp -ura media, to screen for diploid cells. The state of 
the GR526 protein within the diploid cells was investigated by randomly selecting two diploid 
colonies from each mating, growing them in liquid media and plating them on galactose-
supplemented X-gal dropout media, as previously described (3.2.9). 
3.3. Results 
3.3.1. Expression of the GR526 protein occurs in blue and white yeast cells 
In order to confirm that the GR526 protein was expressed in equivalent levels in white yeast 
compared to blue yeast transformed with the rat and human NFoxG l:GR526 constructs, 
western blot analysis was performed, using a GR specific primary antibody. The western blot 
was incubated with both the GR specific antibody and a loading control antibody specific to 
glyceraldehyde 3 phosphate dehydrogenase (GAPDH). The western blot allowed detection of 
the 58 KDa GR526 protein in the cell extracts collected from blue pG I_GR526 transformed 
yeast, used as a positive control (Fig. 3.2). The GR526 protein was absent from untransformed, 
wildtype yeast, used as a negative control. The GR526 protein was expressed in both blue and 
white yeast transformed with the human and rat NFoxG 1 :GR526 constructs. The cell extracts 
collected from white yeast transformed with the human NFoxG 1 :GR526 construct showed 
lower levels of immuno-reactivity to the GR specific antibody, these reduced levels were 
however, maintained when the western blot was incubated with the GAPDH antibody. The 
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The white cells transformed with the human and rat constructs, pG I-hBFl GR526 and pG 1-
rBFIGR526 respectively, were also cured by the protein denaturant, the progeny of the 
originally white colonies expressed soluble GR526 protein, which was able to regulate the ~­
galactosidase reporter plasmid (Fig 3.3.iii & iv). The percentage of colonies converting 
between the active and inactive GR526 conformations was high in the colonies transformed 
with the human NFoxG 1 :GR526 construct, in the ~-galactosidase assay (Chapter 2), thus the 
patches of white cells on X-gal media included a number of blue yeast cells, resulting in a 
faint blue colour. These white cells, when cured, maintained a percentage of white cells, 
resulting in mosaic colonies (Fig. 3.3.iv). 
3.3.3. GR526 proteins extracted from blue and white cells display different sedimentation 
rates 
In order to determine whether the GR526 proteins extracted from blue and white yeast colonies 
had different physical properties, therefore confirming the aggregates seen in the GFP assay 
(Chapter 2), the rate of sedimentation for the proteins was investigated on sucrose gradients. 
Following ultracentrifugation, the gradients were fractionated from the top of the gradient 
downwards and numbered one to ten. Fractions numbered one were excluded from the blots 
due to spatial constraints; this was considered the safest selection based on previously 
published research (Si et ai., 2003). Western blot analysis was performed with both a GR 
specific antibody and a GAPDH antibody as a control. The GAPDH protein was found to 
have the same sedimentation rate in the blue and white cell extracts, with the greatest 
percentage of the protein detected in fractions three, four and five (when numbering from the 
top of the gradient downwards) of all samples (Fig 3.4.A). This result confirms that 
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Similarly, the gradient fractions were investigated by western blot analysis with a GR specific 
primary antibody. The western blots revealed that the GR526 proteins sedimented at a different 
rate when extracted from blue versus white yeast colonies. The soluble GR526 proteins 
extracted from blue colonies transformed with the control non-prion plasmid, pG I_GR526, the 
. . 526 S~6 5~6 pnon control plasmId pGI-NMGR ,pGl-hBFIGR- and pGl-rBFIGR - were all present 
predominately in fractions three, four and five (Fig. 3.4.B), like the soluble GAPDH protein 
(Fig. 3.4.A). The GR526 proteins extracted from white colonies transformed with the plasmids 
pGI-NMGR526, pGl-hBFIGR526 and pGl-rBFlGR526 sedimented predominantly to fractions 
six, seven and eight (Fig. 3.4.B). These results suggest that while the functional GR526 
proteins extracted from blue yeast colonies sediment at the same rate as a soluble yeast 
protein, namely GAPDH, the inactive GR526 proteins isolated from white yeast colonies 
sedimented at a higher rate and are in a denser, aggregated form. 
3.3.4. Suh-cloning of the FoxGl N-terminal domains and GR526 into the vector pYES2 
In order to perform the yeast mating experiment, the NFoxG 1 domains fused to GR526 and the 
Sup35 NM domain fused to GR526, were sub-cloned into the yeast expression vector pYES2, 
.. 5~6 S~6 526 WIth a uracIl selectable marker. The NM:GR -, hNFoxG l:GR - and rNFoxG 11 :GR 
fragments were digested out of the original constructs, and ligated into the p YES2 vector in 
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Following yeast mating, diploid cells were selected for on triple dropout media. Two diploid 
cells for each mating were plated on X-gal supplemented media, to determine the colour of 
the progeny, resulting in six plates per performed cross mating (matings performed in 
triplicate, and two diploid cells selected from each one). The diploid colonies that resulted 
from the mating of the yeast carrying the two NM:GR526 plasrnids and pL2/GZ were white in 
colour, as expected (Table 3.3, Fig. 3.8). The diploid progeny from the human NFoxG 1:GR526 
matings were all white in colour, demonstrating that the inactive form of the GR526 protein, 
when fused to the human NFoxGl, is transmissible. The progeny from the rat NFoxG1:GR526 
matings were predominantly white: five of the six matings produced all white colonies, while 
the two diploid cells selected from one mating (the third blue a-type colony crossed with a 
white a-type colony in Fig. 3.7) produced half blue and half white colonies (Table 3.3, Fig. 
3.8). 
Table 3.3. Each mating was performed in triplicate, and the colour of two diploid cells determined on X-
gal media. The number of blue, white and mixed plates out of six, for each mating was recorded. 
Yeast mating No. of blue progeny No. of white progeny No. of mixed plates 
NM white a x blue a 0 6 0 
NM blue a x white a 0 6 0 
Human NFoxG 1 white a x blue a 0 6 0 
Human NFoxG 1 blue a x white a 0 6 0 
Rat NFoxG 1 white a x blue a 0 6 0 
Rat NFoxG 1 blue a x white a 0 4 2 











F ;~UH' J.K The ;nae1;n , 'alt' ollhe ~Fo~Gt,CR"" prole;" ;, ;nf~e1io"". I he COIoUI of lhe d;pio,d l>ro~cn) 
of ,,,,, yc"" malLng' "'''-, de1cnr. ",-"J h)' ~r(),,"h ,," X-gal ,ul~~em.onlCJ meola_ (AI The p"'g.o"), of lhc 
N\I:GR'" ma'in~' ",cr.o a ll ",h,lc (III Th e progeny I'rom Llk: "uIMn KI'<,,(il'GR'" malrn~' ",.o r.o all """ ... 
deITl(ln'lmling Ilk: in""'1i " t()fm "f rhe pr04cin i, "an,ml'<lh l,,_ nc pmgeny Irom li"c of lhe mL NF",(i l :(iR'" 
maL in~' were "h1lc {Cl, "' '' ile lhc b"- or lh< maLin~' rc,uhcJ in.,O % hiLI< and 50 ,+ "hile colonic,_ "hen 
rlal.od ()Il X _~al medl" The dlfferen.:.'" rn [he """kg"'""" mc>dia ,'ol()Ur ""ere noll due to d lfferen,'e, in med,a 
<()lnpoMIIon . 
In Ihis chaplCf, lile physical propcnic, Oflile mal'I, \'C , laiC oflhe GR~ '" prolein, ,cen 111 Ihe 11-
gJI ~<:t(lsida,c a"ay in ChJplcr 2. we re ill\'csligalcd. 11 was f<lUnd that the while colonies seen 
in lhc assay were n()t dLJC I() reduced cxprc~, i () n of Ill" GR ' , (, prolein, Or du" 10 T llu l ~li on_ The 
inactive form of Ihc pWlein was found to have a dll'ferent ",dimcntal,oll rale, when compared 










to the active form, providing further evidence for the formation of aggregates, initially seen in 
the GFP assay (Chapter 2). Infectivity of the amyloid forms of the NFoxG 1 :GR526 constructs 
were also investigated via yeast mating, it was shown that the inactive, aggregated state of the 
protein was transmissible to uninfected cells, akin to prion proteins. 
It was initially hypothesized that the white colonies seen in the p-galactosidase assay could be 
a consequence of one of three distinct mechanisms, namely the reduced expression of the 
GR526 protein, a mutation in the GR526 protein which had occurred in the process of 
transformation and growth of the cells, or alternatively a consequence of a conformational 
switch and formation of amyloid fibres typical of prion proteins. These alternatives were 
in ves tigated. 
The possibility that reduced levels of the GR526 protein could account for the inability of the 
protein to active the p-galactosidase reporter was ruled out by western blot analysis, 
performed with a GR specific antibody. The analysis showed that the protein was expressed 
in blue colonies transformed with the GR526 construct, pG l_GR526, and was absent in 
untransformed cells. The GR526 protein was found to be expressed in comparable levels in 
white and blue colonies carrying the human and rat NFoxG 1 :GR526 constructs. Incubating the 
western blot membrane with a loading control antibody to GAPDH, revealed that the levels of 
GR526 protein within blue and white cells did not differ significantly (Fig. 3.2). The white 
colour of the colonies seen in the p-galactosidase assay was therefore not due to a lack of 











An alternative explanation could be that the white colonies were a consequence of a mutation 
in the NFoxG 1 :GR526 sequence. This was tested by growth of white colonies on GuHCl. 
Known prions can be cured by growth on GuHCl (Chernoff et ai., 2002), while proteins in 
which a mutation has occurred cannot. The white colonies transformed with the prion control 
NM:GR526 construct were found to be cured by growth on GuHCI supplemented media, as 
expected (Li and Lindquist, 2000). In Chapter 2, one white colony was identified from those 
transformed with the GR526control plasmid, which provided a convenient positive mutation 
control. This colony was also subjected to growth on GuHCl and it was shown to be 
incurable, indicating that it resulted from a random mutation in the GR526 sequence and not 
from a prion-like mechanism (Fig. 3.3.i). The white cells transformed with the human 
S76 57 6 construct pG I-hBF 1 GR - and the rat construct pG l-rBF 1 GR - were both found to be cured 
(Fig. 3.3.ii & iii). The progeny colonies were blue in colour, but the strain with the human 
NFoxG 1 construct maintained a number of white colonies, giving them a mosaic appearance. 
This mosaic colony phenomenon was consistent with the instability of the human 
NFoxG 1 :GR526 protein conformation seen in the ~-galactosidase assay (Chapter 2). The 
curing of the inactive state of the GR526 protein in the yeast transformed with the rat and 
human constructs suggests a prion-like mechanism, but does not provide definitive evidence. 
Thirdly, white yeast colonies could have resulted from GR526 protein aggregation induced by 
the NFoxG 1 domain. This was partially tested in Chapter 2 by fusing the NFoxG 1 domain to 
GFP and viewing aggregates with fluorescent microscopy. The presence of aggregates, a 
characteristic of prion-like mechanisms, was investigated by sucrose gradient fractionation. 
The sedimentation rates of the NFoxG l:GR526 proteins extracted from blue and white 











active and inactive states of the protein. Incubation of the western blot membranes with the 
control GAPDH antibody revealed that the protein sedimented to the fractions numbered 
three, four and five from the top of the gradients, and showed that fractionation through the 
sucrose gradients was similar in all experiments (Fig. 3.4.A). The GR526 proteins from blue 
colonies sedimented at the same rate as the GAPDH protein, with the majority of the protein 
present in the third, fourth and fifth fractions from the top of the gradient. GR526 proteins 
isolated from white colonies, however, sedimented to fractions six, seven and eight (Fig. 
3.4.B). These results show that the inactive GR526 protein present in the white colonies is 
present in a denser and more aggregated form than the GR526 protein isolated from blue 
colonies, in which it is active. The results described in this chapter therefore provide evidence 
that the white colour of the colonies seen in the p-galactosidase assay in Chapter 2, are a 
result of a conformational change and high molecular weight aggregate formation. 
Thus far I have shown that the N-terminal domains of the human and rat FoxG 1 transcription 
factors share a number of traits with prion proteins. These include: conformational flexibility 
and tracts of amino acid residues, an ability to confer upon other proteins (GR526 and GFP) a 
reversible change in conformation from the soluble form to the insoluble, aggregated form, 
and the ability of the aggregated form to be cured by a protein denaturant. These traits 
suggest, but do not prove, a prion-like mechanism. As previously discussed, not all proteins 
capable of distinct conformational states are prions; prions (for example mammalian Prpsc and 
Ap/ysia CPEB) are proteins capable of infectious amyloid formation, while other amyloid 
forming proteins exist, which are not infectious (for example those responsible for Alzheimer 











Yeast prion states are able to produce non-pathogenic, heritable changes in phenotype, which 
are transmissible and infectious between mating cell types and show non-Mendelian patterns 
of inheritance (Chernoff et ai., 1995, Sondheimer et aI., 2001). Mammalian prion diseases 
which include Creutzfeldt-lakob disease and bovine spongiform encephalopathy, are 
infectious diseases resulting in severe neurodegeneration (Prusiner, 1998). Mammalian 
neurodegenerative diseases resulting from protein amyloid formation include Alzheimer 
disease, which results from aggregation of the p-amyloid precursor protein (PAPP), and 
Parkinson's disease, resulting from the accumulation of Lewy bodies, aggregates of the a-
Synuclein protein (Checler and Vincent, 2002, Taylor et aI., 2002). Alzheimer and 
Parkinson's disease, although similar to the prion neurodegenerative diseases in the 
accumulation of protein deposits in brain tissue, are not considered prion diseases, as the 
disease state is not infectious. Thus, in order to determine whether the N-terminal domains of 
FoxG 1 orthologues are amyloid forming proteins or prion proteins, the transmissibility of the 
aggregated conformation was investigated through a yeast mating experiment. 
In the yeast mating experiment the NM:GR526 fragment was used as a positive prion control. 
Previous research has revealed that the amyloid state of the NM:GR526 protein is transmissible 
between mating cell types, giving rise to diploid progeny that maintain the prion state of the 
protein (Li and Lindquist, 2000). Yeast mating of blue and white colonies carrying the pG 1-
NMGR526 constructs resulted in white colonies (Fig. 3.8.A). The mating of blue and white 
colonies derived from the cells transformed with the human NFoxG 1 :GR526 constructs, also 
resulted in white diploid progeny (Fig. 3.8.B). Five of the matings of blue and white yeast 
colonies carrying the rat NFoxG l:GR526 constructs resulted in white progeny, the remaining 











known yeast prion states are non-Mendelian elements and are usually dominant, some have 
shown unusual segregation ratios. These range from 4:0 to 0:4 (prion state:soluble state) in 
the progeny, during yeast mating experiments. These ratios can be explained by the fact that 
some of the yeast may lose the prion state of the protein during meiosis. Another explanation 
for the 2:2 ratio seen in the one rat NFoxG l:GR526 mating is the possibility that one parent in 
the mating contained a mutation which prevented prion fibre propagation (Chernoff et ai., 
2002). 
These results demonstrate that the high molecular weight forms of the human and rat 
NFoxG 1 :GR526 proteins are able to act as prion-like transmissible proteins, able to self-
proliferate and infect yeast mating pairs. Besides the Aplysia CPEB protein, this is the second 
neural protein to display the ability to change conformation and propagate the alternative 













The purpose of this study was to investigate the possible prion-like properties of the N-
terminal domains of the winged-helix transcription factor FoxG 1. Prion proteins, which are 
able to form self-proliferating, infectious amyloids, are responsible for neurodegenerative 
diseases in mammals, such as bovine spongiform encephalopathy, and non-Mendelian traits 
in yeast, for example the yeast prion states [PSr], [Urd] and [RNQ1] (Chernoff et aI., 1995, 
Prusiner, 1998, Sondheimer et al., 2001, Wickner et aI., 1994). The amino acid sequences of 
these proteins are often glutamine rich and include oligopeptide repeat sequences (Derkatch et 
al., 2004). The N-terminal domains of prion proteins are also dispensable for their function 
and often display conformational flexibility. Similar amyloid proteins exist which are 
responsible for neurodegenerative diseases in mammals, but are not considered prions, due to 
their non-infectious nature; these include those proteins responsible for Alzheimer and 
Parkinson's disease (Dobson, 2003). 
The mammalian orthologues of the FoxG 1 transcription factor were of particular interest due 
to the unusual composition of their N-terminal domains. The DNA-binding and C-terminal 
domains are highly conserved amongst vertebrates; the DNA-binding domains all contain the 
100-amino acid region characteristic of the winged-helix family, while the C-terminal 
domains contain a conserved 211 amino acid domain (Bredenkamp et aI., 2006). The N-
terminal domains have in common the first 30 amino acid residues, including a Casein kinase 











vertebrates (Regad et al., 2006). The N-terminal domains of the mammalian orthologues 
contain significant quantities of histidine, proline and glutamine amino acid residues, regions 
significantly reduced in lower vertebrates such as Xenopus and zebrafish. The human 
sequence contains the greatest number of these amino acid residues, with an insertion of a 
poly-proline tract of six residues, which is absent in the rat sequence. It was this expanded 
domain that led to the hypothesis that the N-terminal domain might act as a prion-like switch 
and regulate the protein in some manner. 
In this study, I initially showed that the NFoxG 1 domains of the human, rat and Xenopus 
orthologues displayed high levels of conformational flexibility, similar to the N-terminal 
domains of some of the known prions. It was evident that the level of flexibility in the domain 
increased with the number of histidine, glutamine and proline residues, with the human 
sequence displaying the highest level of sustained flexibility and the greatest number of these 
residues. The human and rat orthologues were chosen for further experimental work, to 
compare differences in their prion-like properties. 
The human and rat NFoxG I domains were found to be able to alter the conformation of other 
proteins, namely the glucocorticoid receptor and green fluorescent proteins. In the yeast ~­
galactosidase assay, the NFoxG 1 domains were fused to the constitutively active GR526 
protein, and the effect of the domain assayed via a GR526 regulated LacZ reporter construct. 
Both the human and rat NFoxG 1 domains were able to alter the conformation of the GR526 
protein, rendering it inactive and resulting in white yeast colonies. Further experimental work 
established that the white colonies seen in the ~-galactosidase assay were a result of aggregate 











one of three possibilities: the first was that the GR526 protein was expressed at lower levels in 
the white colonies when compared to blue, alternatively that the GR526 had become mutated in 
the white colonies, or thirdly that the NFoxG 1 domain induced an alternative, aggregated 
conformation of the GR526 protein. Western blot analysis, growth on a protein denaturant and 
the investigation of the sedimentation rates of the GR526 proteins in blue and white colonies, 
combined with the earlier results of the GFP assay, provided evidence that the white colour of 
the colonies was a result of aggregate formation. With the use of a yeast mating experiment, 
the transmissible nature of the aggregates induced by the NFoxG 1 domains was displayed. 
In the ~-galactosidase assay, the human NFoxG 1 :GR526 fusion protein was found to switch 
between the active and prion state of the protein at a significantly higher rate than the rat 
fusion protein, which was comparable to the N-terminal domain of the known yeast prion 
Sup35. Research on the Sup35 N-terminal domain has shown that the insertion of additional 
amino acid repeat sequences results in the conversion from the active to the inactive state of 
the protein at a significantly higher rate than the wildtype protein, due to different [PSI+] 
strain formation (Liu and Lindquist, 1999). It is suggested that the instability of the human 
NFoxG 1 domain was a result of the expanded proline domain absent in the rat sequence, 
resulting in differences between the human and rat NFoxG 1 prion strains, which may differ in 
size and structure of the likely amyloid fibres (Tanaka et ai., 2004). 
Although I have shown in these yeast assays that the NFoxG 1 domains display prion 
characteristics, a number of questions remain regarding the biological importance of the N-
terminal domain in regulating FoxG 1 in neural progenitor cells. The FoxG 1 transcription 











genes by interacting with the Gro/TLEI complex (Yao et al., 2001) and activating 
transcription by binding to Smad proteins and Smad binding partners, disrupting the TGF-~ 
pathway (Dou et al., 2000, Rodriguez et al., 2001). FoxG 1 is also known to act in a dosage 
dependent manner, stimulating proliferation in high concentrations and differentiation in low 
concentrations (Bourguignon et al., 1998). Bone morphogenic protein and fibroblast growth 
factor-8 are also believed to be regulated by FoxG 1 (Hanashima et al., 2002, Martynoga et 
al., 2005). Understanding how the formation of prion amyloids applies to the complex 
interactions and pathways involved in repression and activation of transcription is an 
immense task, and the purpose of such a mechanism in early telencephalic development 
remains to be explored. The Aplysia CPEB protein has been shown to be more active in the 
prion conformation, than the soluble conformation, able to bind CPE containing RNA (Si et 
al., 2003). Thus, it is possible that the prion form of FoxG 1 may be active and confer an 
alternative role for FoxG 1 in development, or may be inactive and a means for FoxG 1 
disruption. 
Thus, future research should first investigate whether the aggregated or soluble state of 
FoxG 1 is the active conformation of the protein. It is suggested, that in order to do so, the full 
length FoxG 1 protein be fused to the GR526 protein, to confirm that it is able to confer the 
same conformational change seen in this study, and investigate the effects of the DNA-
binding and the C-terminal domains on amyloid formation. It would be interesting to map the 
exact amino acid residues in the N-terminal domains required for prion aggregate formation, 
and determine whether the insertion of the six proline residues in the human sequence results 
in the instability seen in this study, by creating a mutant in which the insertion is deleted. It 











human and rat transcription factors, and investigate whether the difference in prion strains has 
any connection to the vast difference in cerebral cortex size seen between the orthologues 
(Hill and Walsh, 2005). Perhaps the N-terminal domains of lower vertebrates can be similarly 
tested, to determine whether the mammalian orthologues are unique in their prion properties. 
The results generated by this study are very exciting, providing proof of a second neuronal 
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